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Challenges in drug efficacy occur during the treatment of most types of cancer due to the 
heterogeneity of the tumor microenvironment. This has led to the development of personalized 
medicine. Due to the clinical success of the proteasome inhibitors Bortezomib and Carfilzomib 
in treatment of multiple myeloma, interest has shifted towards molecularly-targeted 
chemotherapeutics for ubiquitin-proteasome system (UPS). Deubiquitinating enzymes (DUBs) 
are an essential part of this pathway which have been found to promote Bortezomib resistance in 
multiple myeloma patients. Unfortunately, there is a lack of specific, high throughput 
biochemical assays to characterize DUB activity in patient samples before and after treatment 
with DUB inhibitors. Therefore, there is a need for novel biochemical assays for quantifying 
DUB activity in a single cell level. In this research, a long-lived, cell permeable, peptide-based 
reporter was developed to directly quantify DUB activity in intact single cells.  A hallmark of 
this reporter is the use of a β-hairpin ‘protectide’ which can confer its stability to enzyme 
substrates. First, a study was performed to determine if the arginine-rich β-hairpin sequence 
motif could behave as a cell penetrating peptide (CPP). Chapter 2 highlights these findings and 
confirms that the RWRWR β-hairpin sequence could be rapidly internalized into intact cells. 
Chapter 3 summarizes findings from another study that investigated the use of incorporating D-
chirality amino acids into CPPs. The D-chirality peptides were confirmed to be highly stabled 
under intracellular conditions and were found to be rapidly internalized. Next, a microfluidic 
droplet trapping array was developed to encapsulate and analyze the intracellular fluorescence of 
intact single cells. Chapter 4 summarizes the development of this device and its use to identify 
distinct subpopulations that emerge with respect to the CPP uptake. Finally, Chapter 5 utilizes 
the findings from Chapter 2 to develop a long-lived, cell permeable, fluorescent, peptide-based 
vii 
reporter for DUB activity. This chapter confirms the utility of this reporter in both cell lysates 
and intact cells. In summary, a set of toolkits including CPPs, a microfluidics droplet trapping 
array, and peptide-based DUB reporter were developed to provide a new platform for drug 







Chapter 1: Background and Significance 
1.1 Cancer and Molecularly Targeted Therapeutics 
Cellular heterogeneity and complexity found in the tumor microenvironment make the 
treatment of such malignancies extremely challenging. Interpersonal diversities including age, 
race, sex, environment, and other factors cause patients to respond to chemotherapy in a 
personalized manner. Unfortunately, the equal classification of patients into fixed categories and 
relying on databases that ignore these diversities may not be efficient for accurate cancer 
diagnosis and treatment. As a solution, personalized medicine has gained tremendous attention in 





 have dramatically increased patient prognosis and survival. 
Multiple myeloma (MM) is cancer formed by malignant plasma cells in the bone marrow that 
leads to a decreased immune response, weakening of the bones, kidney failure, and congestive 
heart failure
3
. The American Cancer Society estimates the lifetime risk of getting multiple 
myeloma is 1 in 143 with ~24,000 new cases diagnosed per year and ~11,000 expected deaths 
per year. The ubiquitin-proteasome system (UPS) is an essential pathway that is primarily 
responsible for recognizing and degrading proteins that are misfolded, dysregulated, or no longer 
needed in the cells
4
. Protein ubiquitination is governed by a cascade of three enzymes (E1-E3) to 
conjugate ubiquitin to a lysine on a target protein leading to the formation of a polyubiquitin 
chain
5
. The polyubiquitin chain recruits the target protein to the proteasome where it is degraded. 
Bortezomib and Carfilzomib were effective in the treatment of multiple myeloma because MM 
cells are proliferative: they over-produce defective proteins which need to be degraded by the 
proteasome and results in up-regulation of proteasome-dependent signaling pathways. Inhibiting 
the proteasome causes misfolded and damaged proteins to accumulate in the cells which 
2 
ultimately causes cell death. Deubiquitinating enzymes (DUBs) are an essential part of the UPS 
that act as a recycle system by removing the polyubiquitin chain and rescuing the protein. 
Recently, work in the Anderson lab has identified that DUBs facilitate Bortezomib resistance in 
multiple myeloma
6, 7
. Therefore, DUB inhibitors have been proposed as a secondary treatment to 
enhance Bortezomib efficacy in high risk patients where Bortezomib alone has been found to be 
ineffective.   
1.2 Current Methods for Quantifying DUB Activity 
Current biochemical assays available for measuring DUB activity are limited to cell-free 
or lysate-based reactions or require complex genetic manipulations which are not convenient due 
to small sample sizes. The current gold standard for DUB reporting consists of a full length 
ubiquitin molecule with a fluorophore (e.g, 7-amino-4-methylcoumarin-AMC, λex = 354, λem 
=442) conjugated to the C-terminus.
8, 9
 The underlying principle for this reporter is that as long 
as the fluorophore is bound to the substrate (Ub), no fluorescence will be observed in the sample. 
DUB-mediated cleavage of the reporter frees the fluorophore and results in an easily detectable 
fluorescent signal that can be measured using methods like fluorometry. Recently, this reporting 
scheme has been improved to incorporate more sensitive fluorophores
10, 11
, different analytical 
outputs
11, 12
, or FRET pairings
13
 to enhance the sensitivity to measure DUB activity. However, 
all of these reporting schemes are not compatible with intact cells, which limits their utility to 
bulk, end-point measurments that cannot capture the heterogeneous nature of cancer cells. To 
address this need, novel reporters of DUB activity are required that do not relying on static, end-
point measurements in cell lysates, but can be incorporated in intact single cells where they 
remain stable under cytosolic conditions and are sensitive and specific to DUBs. Additionally, 
3 
this reporting scheme should be compatible with high-throughput single cell analysis techniques 
like capillary electrophoresis, mass cytometry, and/or droplet microfluidics
6
.    
1.3 High Throughput Single Cell Analysis for Addressing Tumor Heterogeneity 
Most of the currently available biochemical assays depend on static measurement of bulk 
samples that cannot directly measure enzyme activity in intact cells. Dynamic, high throughput 
screening (HTS) of intact single cells provides subtle information about the tumor population 
and can facilitate the identification of potential drug-resistant subpopulations. Example 







. Traditionally, flow cytometry has been the gold standard 
for single cell analysis; however, the large size and expensive price of the equipment limits its 
availability to many clinics and labs. Additionally, analysis with flow cytometry is often limited 
to cell surface markers and cannot capture the intracellular heterogeneity of a fluorescent 
signal
19
. Microfluidic devices are ideal for performing HTS due to their ease of use, low reagent 
costs, high reproducibility rates, and compatibility with biological samples and molecular probes. 
These devices have the potential for process automation and parallelization, and different types 
of manipulations and markers may be implemented to perform various types of analyses with 
them. In recent years, droplet microfluidic devices have revolutionized the state of single cell 
analysis by facilitating high-throughput screening by encapsulating individual cells in rapidly 
generated picolitre-sized aqueous droplets in a continuous oil phase. Recent efforts have shifted 
to incorporate on-chip trapping arrays to eliminate off-chip incubation steps and allow for 
dynamic analysis without the need for expensive fiber optics or high-speed cameras. The static 
microdroplet array, first developed by Huebner et al
20
, allowed for the trapping and analysis of 
individual cells in single droplets. Improvements to this motif have been made to include fluidic 
4 
traps with a bypass channel to facilitate single droplet trapping or overhead trapping arrays to 
separate and collect single droplets due to the immiscibility of the aqueous and oil phases. 
Incorporating a droplet trapping array in a droplet microfluidic platform facilitates dynamic high-
throughput screening of single cells on-chip while minimizing the chance for contamination and 
decreasing operator influence. 
1.4 Overview of the Presented Research 
In this research, an interdisciplinary approach is applied to develop a bioanalytical 
method to directly measure DUB activity in intact single cells using a fluorescent, peptide-based 
reporter that is cell permeable and long-lived. Dynamic high-throughput, single cell analysis is 
facilitated by the development of a microfluidic droplet trapping array. A schematic of the 




Figure 1.1. Schematic of project overview (A) Fluorescent, long-lived, cell permeable reporter 
of DUB activity is incorporated into intact single cells. (B) A heterogeneous population of cells 
with differential DUB activity results in varying fluorescent intensities. (C) Direct measure of 
DUB activity in intact cells using a microfluidic droplet trapping array 
5 
The project is broken into four major parts: 
1.4.1 CPProtectides: Rapid Uptake of Well-Folded β-hairpin Peptides with Enhanced 
Resistance to Intracellular Degradation 
The goal of this chapter was to synthesize and characterize a library of cell penetrating 
peptides with enhanced protease resilience. The intracellular stability of CPPs is important 
because rapid degradation in cells can prevent efficient cargo delivery. Also, CPPs with 
enhanced intracellular stability are ideal for performing long-term, dynamic measurements in 
intact cells by being incorporated in cell permeable biosensors. The library contained sequences 
based on a β-hairpin sequence motif which was previously established to be highly stable under 
intracellular conditions. Peptide uptake was quantified by fluorometry and visualized by 
fluorescent microscopy. The library of peptides were identified as CPPs that demonstrated 
superior intracellular stability with a 4-fold increase in half-life over commercially-available, 
unstructured counterparts. The effects of temperature, concentration, and the secondary structure 
on cell permeability was also studied which identified a tradeoff between uptake kinetics and 
long-term stability. 
1.4.2 Uptake Kinetics of Protease Resistant D-Chirality Cell Penetrating Peptides in 
Mammalian Cells 
In this chapter, an alternative strategy was explored to develop CPPs with enhanced 
intracellular stability that did not exhibit the decrease in uptake efficiency found peptides with a 
β-hairpin motif. A popular strategy to enhance the intracellular stability of peptides is to alter the 
stereochemistry of the amino acid residues in the sequence from L to D. In theory, these peptides 
will remain stable in the intracellular environment since the non-natural D configuration amino 
acids is not recognized by proteases and peptidases. In this chapter, a library of D-chirality CPPs 
were designed, synthesized, and characterized. These peptides demonstrated rapid uptake in 
intact HeLa cells and superior stability under cytosolic conditions. Time, temperature, and 
6 
concentration dependence of peptide uptake was characterized and compared to their L-chirality 
counterparts. Interestingly, the D-chirality peptides demonstrated significantly higher cell 
permeability efficiency compared to their L-chirality counterparts demonstrating that chirality 
switching enhanced the internalization capabilities of these sequences.  Despite the expectations 
and the proven cytosolic stability of these peptides, a time-dependent decrease in intracellular 
fluorescence was observed. It was hypothesized that D-chirality peptides were expelled by the 
cells via an extrinsic mechanism after internalization. This phenomenon was previously 
described for Poly(D,L-Lactide-co-Glycolide) (PLGA) nanoparticles
21
; however, this has never 
been described with D-chirality peptides, and the cellular export mechanisms regulating this 
process are currently unknown. Development of cell penetrating peptides as efficient delivery 
vectors for intracellular drugs or biosensors would depend on their permeability efficiency, 
intracellular stability, and retention in the cells. Therefore, it is important to investigate the 
presence of such export mechanisms for non-natural sequences and characterize them. Therefore, 
further studies were performed which identified that peptide expulsion was dynamic and energy-
dependent. This process was enhanced in the presence of serum and diminished at lower 
incubation temperatures. Considering the application of incorporating D-chirality amino acids in 
CPPs as a strategy to confer protease resilience to cell penetrating peptides, the findings from 
this study has merit in a number of applications ranging from drug delivery to biosensing 
motivating a need for further studies on D-chirality peptide internalization and retention. 
1.4.3 Population-Based Analysis of Cell Penetrating Peptide Uptake Using a Microfluidic 
Droplet Trapping Array 
 
Droplet-based microfluidic devices have emerged as a highly efficient technique for 
performing high-throughput, single cell analysis of heterogeneous samples. The underlying 
principle involves compartmentalizing single cells in picoliter-sized, mono-disperse aqueous 
7 
droplets in an inert continuous oil phase. Traditionally, this technology has required the use of an 
off-chip incubation step coupled with the need for high-speed cameras to perform static 
measurements of cells or extracellular products
22
. The incorporation of a trapping array 
downstream of the flow focusing junction allows for the dynamic measurement of cellular 
behavior and intracellular enzyme activity on chip. In this chapter, a microfluidic droplet 
trapping array was designed and fabricated to encapsulate cells in aqueous droplets and trap them 
in micro-wells for HTS. The application of the platform was demonstrated by analyzing the 
uptake efficiency of a four different CPPs at the single cell level across a population. The tested 
peptides include two commercially available sequences (TAT and ARG) and two novel peptides 
previously described in section 1.4.1 (RWRWR and OWRWR). The effect of initial peptide 
concentration was studied on peptide uptake efficiency, population distribution, and intracellular 
peptide distribution. Rigorous statistical analysis was performed to characterize and predict the 
population behavior. This study found that distinct subpopulations exist with dramatically high 
uptake efficiencies which can skew bulk measurements used to compare and rank peptide 
uptake. 
1.4.4 Direct Quantification of DUB Activity in Intact Cells Using a Protease-Resistant, Cell 
Permeable, Peptide-Based Reporter 
In this chapter, a unique reporter of DUB activity was designed, synthesized, and 
characterized. This novel biosensor conjugates a four amino acid substrate, derived from the C-
terminus of ubiquitin (LRGG), onto the C-terminus of the β-hairpin peptide RWRWR. As an 
analytical output, the fluorophore AFC is conjugated onto the C-terminal glycine residue of the 
resulting peptide that, when cleaved by DUBs, produces a detectable signal by fluorometric 
techniques. Kinetic analysis of reporter performance was characterized in HeLa and OPM-2 (a 
myeloma-derived cell line) lysates and compared to a non-cell permeable commercially available 
8 
DUB reporter (Z-LRGG-AMC). The specificity of the reporter to DUBs was confirmed by 
analyzing samples in the presence and absence of the small molecule DUB inhibitor (PR-619). 
Enzyme kinetics were characterized by non-linear regression analysis to numerically simulate 
the experimental data using the Michaelis-Menten model to calculate the rate constants. The 
potential for the reporter to measure DUB activity in intact cells was evaluated using fluorometry 
and fluorescent microscopy techniques. Uptake kinetics and reporter performance in single intact 
cells were demonstrated and characterized using both fluorometry and fluorescent microscopy in 
HeLa cells. In all cases non-linear regression analysis was performed to mathematize and predict 


















Chapter 2: CPProtectides: Rapid Uptake of Well-Folded β-hairpin Peptides 
with Enhanced Resistance to Intracellular Degradation 
This chapter is reproduced from an article accepted for publication in Peptide Science. 
Authors: Nora Safa
1











, Ted J. Gauthier
2
, and Adam T. Melvin
1
   
2.1 Introduction 
Cell penetrating peptides have emerged as powerful tools for delivering bioactive cargoes 
into the cytosol of intact cells for therapeutic and sensing purposes. These short, charged 
sequences can be incorporated into biomaterials, antimicrobial drugs, anticancer therapeutics, 
small molecule inhibitors, intracellular probes and more.
23-25
 In recent years, several new types 
of CPPs have been identified with a range of primary and secondary structures in an attempt to 
increase cellular uptake and intracellular targeting of biomolecules
26
. The need for incorporating 
CPPs into biosensors has increased in recent years due to novel single cell analysis techniques.
27
 
These high-throughput screening approaches have relied upon electroporation and microinjection 
to introduce peptide-based reporters into single intact cells.
28
 In addition to peptide-based 
reporters, CPPs have found an important role in the development of novel therapeutics 
compounds called PROTACs (proteolysis targeting chimeras). These peptides take advantage of 
the naturally occurring ubiquitination machinery inside of the cells to target ‘undruggable’ 
proteins such as FKBP12, ErbB3, and the tau protein to the proteasome for degradation.
29
 Many 
of the early PROTAC sequences incorporated CPPs to facilitate the uptake of the peptides into 
the cells to allow for the targeted degradation of specific proteins; however, these PROTACs 
suffered from high protease susceptibility and low cell permeability which decreased their 
overall utility as new therapeutic compounds.
30
  Despite the vast potential of CPPs, one 




resulting in a time-dependent decrease in biomolecule concentration at the active site which can 
lead to decreased efficacy for CPP-tagged drugs or poor analytical signals for CPP-tagged 
biosensors.
31
 Thus, there is a need to design novel CPPs with sufficient uptake efficiency 
coupled with enhanced resistance to protease-mediated degradation. A recent review by 
Kristensen and colleagues
31
 identified this need and highlighted current approaches to increase 
the lifetime of CPP-tagged peptides under cytosolic conditions. Strategies for developing 
protease-resistant CPPs include incorporating D-amino acids,
33
 introducing non-natural groups 
like β-amino acids or N-methylated amino acids,
34, 35
 or modifying peptide backbone by 
macrocyclization.
32, 36, 37
 One challenge associated with these strategies is that in an effort to 
increase peptide stability, uptake efficiency is compromised. Hence, there exists a trade-off 
between peptide internalization efficiency and enhanced intracellular stability.
31, 38
  
While several different cyclic CPPs have been developed
32, 37, 39
, one area that has not 
been studied is developing CPPs with a pronounced secondary structure designed to impair 
degradation by intracellular peptidases. Prior work has identified the utility of ‘protectides’, 
peptide sequences exhibiting a β-hairpin secondary structure that are resistant to degradation by 
peptidases and proteases.
40, 41
 Unstructured peptides gain entry to the catalytic cleft of peptidases 
and are degraded on the order of seconds to minutes,
42
 while structured peptides like β-hairpins 
cannot enter the catalytic site and thus remain intact for several hours.
40, 41
 These protectides 
have the ability to confer this stability to unstructured peptide substrates via conjugation at the 
N-terminus, resulting in highly stable biosensors.
40, 43
 A sequence first identified by Cline et al, 
WKWK (Ac-RWVKVpGOWIKQ-NH2)
40, 41
 consisted of several positively charged amino acid 
residues (lysine, arginine, and ornithine) as positions 1, 4, 8, and 11 coupled with a d-Pro-Gly β-
turn to establish the secondary structure which increases intracellular stability. Coupling 
11 
arginine- and proline-rich sequences for the generation of structured CPPs with enhanced 
intracellular stability has also been explained by Daniels and Schepartz.
38
 Recent work by 
Houston et al found that replacing the lysine residues with ornithine or arginine further increased 
intracellular stability and also converted the β-hairpin sequence into a primary degron capable of 
intracellular ubiquitination.
44
 The goal of this work is to determine if these β-hairpin protectides, 
which are rich in positively charged residues, could also function as CPPs.  To accomplish this, a 
library of β-hairpin protectides were synthesized based on the WKWK sequence with arginine 
and ornithine amino acid substitutions at positions 1, 4, and 11. The effect of time, temperature, 
and concentration on peptide uptake was determined and the internalization efficiencies of the 
peptides were compared to those of unstructured, scrambled versions of the same sequences as 
well as well-known CPPs, TAT and nona-arginine (ARG). Peptide uptake was quantified in 
intact cells using fluorometry and visualized using fluorescent microscopy. The intracellular 
stability of peptides was tested using a degradation assay in cell lysates. The results confirmed 
that the β-hairpin protectides behave as CPPs with rapid cellular uptake in intact cells and 
demonstrate superior intracellular stability compared to unstructured counterparts.   
2.2 Materials and Methods 
2.2.1 Chemicals 
 
Fmoc-protected amino acids, 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3 - 
tetramethylaminium hexafluorophosphate (HCTU), trifluoroacetic acid (TFA) and rink amide SS 
resin were purchased from Advanced ChemTech, Louisville, KY. Nα-Fmoc-Nδ-
allyloxycarbonyl-L-ornithine (Fmoc-Orn(Aloc)-OH) was purchased from Chem-Impex 
International, Inc, Wood Dale, IL. 1-Hydroxy-6-(trifluoromethyl) benzotriazole (HOBt) and 
(Ethyl cyano(hydroxyimino)acetato)-tri-(1-pyrrolidinyl)-phosphonium (PyBOP) were purchased 
12 
from Novabiochem, Billerica, MA. Dimethylformamide (DMF) was purchased from Protein 
Technologies, Tucson, AZ.   Diisopropylethylamine (DIEA), triisopropylsilane (TIPS) 
tetrakis(triphenylphosphine) palladium (0) (palladium), 5(6)-carboxyfluorescein (FAM), 
chloroform (CHCl3), methanol (MeOH), dichloromethane (DCM), and N-methylmorpholine 
(NMM) were purchased from Sigma Aldrich, St. Louis, MO.  Glacial acetic acid was purchased 
from Alfa Aesar, Ward Hill, MA. Acetic anhydride was purchased from Fisher Scientific, Fair 
Lawn, NJ.  
2.2.2 Peptide Synthesis and Purification 
All peptides were synthesized on a Tribute peptide synthesizer (Protein Technologies, 
Tucson, AZ) utilizing a standard Fmoc peptide chemistry protocol on a 100 µmol scale using 
rink amide resin (189 mg, 0.53 mmol/g).  Five-fold excess of Fmoc-amino acids (Fmoc-
Arg(Pbf)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, Fmoc-Orn-OH, Fmoc-d-Pro-OH, Fmoc-Gly-
OH, Fmoc-Ile-OH, Fmoc-Gln(Trt)-OH, Fmoc-Orn(Aloc)-OH) and HCTU, in the presence of 10 
equivalents of NMM were used for each of the amino acid coupling steps (10 min) with NMP as 
the solvent.  A solution of acetic anhydride, NMM and NMP (1:1:3) was added to the 
deprotected resin and shaken for 30 minutes to acetylate the N-terminus of the peptide.  Once the 
peptide synthesis was complete, the resin was washed with DMF (3x30 sec) then DCM (3x30 
sec).  The Aloc group was removed with three-fold excess of palladium in 4 ml of CHCl3-
HOAc-NMM (37:2:1) under nitrogen for 2 hrs.  The resin was then washed with DCM (3x30 
sec) followed by DMF (3x30 sec).  In the dark, FAM was coupled to the delta nitrogen of the 
ornithine side chain with four-fold excess of FAM, HOBt, PyBOP and DIEA in 3mL DMF for 
24 h and then repeated for 8 h.  The peptide resin was washed with DMF (3x30 sec) and DCM 
(3x30 sec). The peptide was cleaved from the resin and side-chain deprotected using 
13 
TFA/water/TIPS (4 mL, 95:2.5:2.5) for 3 hours and collected in a 50-mL centrifuge tube.  The 
cleavage reaction was repeated for 10 minutes. The cleavage solutions for the peptide were 
combined and concentrated in vacuo.  Cold diethyl ether was then added to the peptide solution 
to precipitate the crude peptide.  The peptide was centrifuged for 10 minutes (4,000 rpm) and the 
ether layer decanted.  Fresh cold diethyl ether was added, and the pelleted peptide was 
resuspended.  The peptide was centrifuged again, and the procedure was repeated 5 times in 
total.  After the final ether wash, the peptide pellet was dissolved in 5 mL water containing 0.1% 
TFA, frozen and lyophilized.   
HPLC analysis was performed with a Waters 616 pump, Waters 2707 Autosampler, and 
996 Photodiode Assay Detector which are controlled by Waters Empower 2 software. The 
separation was performed on an Agilent Zorbax 300 SB-C18 (5 um, 4.6 x 250 mm) with an 
Agilent guard column Zorbax 300 SB-C18 (5 um, 4.6 x 12.5 mm).  Elution was done with a 
linear 5% to 55% gradient of solvent B (0.1% TFA in acetonitrile) into A (0.1% TFA in water) 
over 50 min at a 1 mL/min flow rate with UV detection at 442 nm.  Preparative HPLC runs were 
performed with a Waters prep LC Controller, Waters Sample Injector, and 2489 UV/Visible 
Detector which are controlled by Waters Empower 2 software. The separation was performed on 
an Agilent Zorbax 300SB-C18 PrepHT column (7 um, 21.2× 250 mm) with Zorbax 300SB-C18 
PrepHT guard column (7 um 21.2 × 10 mm) using a linear 5% to 55% gradient of solvent B 
(0.1% TFA in acetonitrile) into A (0.1% TFA in water) over 50 min at a 20 mL/min flow rate 
with UV detection at 215 nm.  Fractions of high (>95%) HPLC purity of each peptide and with 
the expected mass were combined and lyophilized. Representative data for the HPLC 
purification and mass spectrometry validation of the RWRWR peptide (Figure 2.2). 
14 
2.2.3 Cell Culture and Lysate Generation 
HeLa cells (LSU AgCenter Tissue Culture Facility) were maintained in Dulbecco’s 
modified eagle medium (DMEM) with 10% v/v fetal bovine serum (FBS, Seradigm). OPM-2 
cells (a kind gift from Nancy Allbritton, UNC) were maintained in RPMI 1640 media 
supplemented with 12% FBS, 21.8 mM glucose, 8.6 mM HEPES (pH 7.4) and 1.0 mM sodium 
pyruvate. THP-1 cells (a kind gift from Nancy Allbritton, UNC) were maintained in RPMI 1640 
media supplemented with 10% v/v FBS and 0.05 mM 2-mercaptoethanol. K562 cells (a kind gift 
from Nancy Allbritton, UNC) were maintained in RPMI 1640 media supplemented with 10% v/v 
FBS. U937 cells (LSU AgCenter Tissue Culture Facility) were maintained in RPMI 1640 media 
supplemented with 10% v/v FBS. All media components were from Corning unless otherwise 
noted HeLa lysates were generated by harvesting 1x10
6
 cells/mL, followed by washing 2X and 
pelleting in phosphate buffered saline (PBS; 137 mM NaCl, 10 mM Na2HPO4, 27 mM KCL, and 
1.75 mM KH2PO4 at pH 7.4). The cell pellet was re-suspended in an approximately equivalent 
volume of mammalian protein extraction reagent (MPER, ThermoFisher) to the volume of the 
cell pellet (~1000-2000 μL) then vortexed for 10 min at room temperature. Following this, the 
mixture was centrifuged at 14,000 x g for 15 min at 4°C and the supernatant transferred to a 
centrifuge tube and stored on ice until use. Total protein concentration was determined using a 
NanoDrop (Thermo Scientific). 
2.2.4 Quantification of Peptide Cell Permeability 
 
The quantification of peptide uptake was performed using a protocol previously 
developed by Qian et al
39
 to evaluate peptide permeability efficiency in a time-, concentration-, 
and temperature dependent manner. Prior to experimentation, all peptides were reconstituted in 
sodium phosphate buffer (2.26 mM NaH2PO4•H2O and 8.43 mM Na2HPO4•7H2O). Stock 
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peptide concentration was determined using a NanoDrop (Thermo Scientific) at the wavelength 
of 492 nm using the UV-vis function. Three days prior to the experiment, HeLa cells were 
seeded at a density of 1x10
4
 cells/mL in 12 well plates (Corning). On the day of experiment, 
peptides were diluted to the desired final concentrations in extracellular buffer (ECB; 5.036 mM 
HEPES pH 7.4 136.89 mM NaCl, 2.68 mM KCl, 2.066 mM MgCl₂ •6H₂ O, 1.8 mM 
CaCl₂ •2H₂ O, and 5.55 mM glucose). The cells were washed 2X with ECB (1 ml/well) 
followed by the addition of the peptide solutions (500 μL/well) for indicated time points at the 
indicated temperatures. All plates were wrapped in aluminum foil to avoid deactivating the FAM 
tag on the peptide. Following the incubation time, the peptide solution was removed, and the 
cells were washed 2X with ECB. The cells were trypsinized (200 μL/well) for 10 minutes at 
room temperature to detach the cells from the wells and remove any remaining peptide adhered 
to the extracellular surface.  The cells were then resuspended in ECB (1mL/well), thoroughly 
mixed, and transferred to microcentrifuge tubes. The samples were centrifuged (1800 rcf, 2.5 
minutes, at room temperature) to isolate the cells. Following centrifugation, the supernatant was 
discarded, and the pellet was lysed with 0.1 M NaOH (250 μL/tube). While the fluorescent 
intensity of FAM has been demonstrated to be dependent upon pH, it was confirmed that the 0.1 
M NaOH had negligible effects on the intensity profile of RWRWR, OWRWR, and S-OWRWR 
peptides at both 10 μM and 30 μM concentrations (data not shown). Each sample was then 
transferred to a 96-well plate and quantified by fluorometry (Perkin Elmer Wallac 1420 Victor2 
multilabel HTS counter). The FAM tag was quantified using an excitation filter of 490 nm and 
an emission filter of 535 nm. During every experiment, a no peptide control was performed (e.g., 
cells incubated with ECB only). In order to measure the background signal of each peptide, the 
peptide solutions used in each experiment was analyzed by fluorometry to normalize the 
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observed fluorescent signal for each sample. All experimentation conditions were performed in 
triplicate with every experiment performed twice to ensure reproducibility. The fluorescent 
signal measured by the plate reader was normalized using equation (1.1): 
Normalized Fluorescence = 1000 ∗
F−C 
P−B
               (1.1)   
where F denotes the fluorescent signal of cells incubated with peptide, C denotes the fluorescent 
signal of cells incubated with no peptide, P denotes the average fluorescent signal of the peptide 
in suspension, and B denotes the average fluorescent signal of the extracellular buffer. This 
analysis was performed to allow for a comparison between the different peptides used in this 
study. Data reported for each peptide is the average of triplicate samples. Standard deviations 
were calculated based on the triplicate samples to obtain the error bars and perform analysis of 
variance. Each experiment was repeated twice to confirm the results. 
Statistical analysis of uptake was performed using ANOVA F-statistics with SAS 
software. The III-67B peptide, a sequence determined to be impermeable to intact cells, was used 
as negative control. To determine the statistical significance of the permeability efficiency of 
each peptide, the normalized signals obtained from that peptide were assessed by statistical t-
tests compared the negative control. For the time-dependent studies, 10 μM peptide was 
incubated with HeLa cells for at 10-minute intervals between 10-100 minutes at 37°C. For the 
peptides that demonstrated insignificant time dependence (rapid internalization) (RWRWR, 
OWRWR, RWOWR, TAT, and ARG) comparison against the negative control was carried out 
based on the 20-minute time point. For the peptides demonstrating time-dependence (slow 
internalization), namely OWOWO and WKWK, this analysis was performed based on the 100-
minute time point. For the temperature-dependent studies, 10 μM peptide solution was incubated 
with HeLa cells for 60 minutes at three different temperature (37°C, 25°C, and 4°C). For the 
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concentration-dependent studies, four different concentrations of peptide (5, 10, 20, and 30 μM) 
solution were incubated with HeLa cells at 37°C for 60 minutes. ANOVA F-statistics were 
performed to assess the statistical significance of the effect of incubation time, incubation 
temperature, and peptide concentration on the normalized fluorometry signals.  
2.2.5 Circular Dichroism 
Peptide concentrations were determined based on the absorbance of FAM at 492 nm. 
Circular dichroism spectroscopy data were collected using a Jasco J-815 CD spectrometer. 
Spectra were generated at 25 °C with a wavelength scan (260−185 nm) using 50 nm/min 
scanning speed in a 0.1 cm cell. Data pitch and accumulation were 1 nm and 3 nm respectively. 
Scan mode was continuous. The smoothing method was Savitzky-Golay with a convolution 
width of 7.  All peptides were at a final concentration of 40 μM in 10 mM sodium phosphate 
buffer (pH 8.02). 
2.2.6 Peptide Degradation Studies 
Peptide stability was determined using a modified version of a degradation assay 
previously described by Cline et al.
41, 45
 Briefly, 30 μM peptide solution was incubated in HeLa 
lysates diluted to a total protein concentration of 2 mg/mL in an assay buffer (10 mM Tris-HCl, 
pH 7.6) at 37°C in the dark. Aliquots of the reaction mixture were removed at set intervals, at 
which point further peptidase activity was quenched by heating the aliquots at 90°C for five 
minutes followed by immediately freezing in liquid nitrogen and then storage at -20°C until 
analysis by HPLC. The 0 min time point measurements were made using lysates that were heat 
killed prior to peptide incubation.  HPLC analysis was performed with a Waters 616 pump, 
Waters 2707 Autosampler, and 996 Photodiode Assay Detector which are controlled by Waters 
Empower 2 software. The separation was performed on an Agilent Zorbax 300 SB-C18 (5 um, 
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4.6 x 250 mm) with an Agilent guard column Zorbax 300 SB-C18 (5 um, 4.6 x 12.5 mm).  
Elution was done with a linear 5% to 85% gradient of solvent B (0.1% TFA in acetonitrile) into 
A (0.1% TFA in water) over 40 min at a 1 mL/min flow rate with UV detection at 442 nm. Peak 
areas were calculated by the Waters Empower 2 software by integration of peaks identified using 
a peak width of 30.00 and a peak threshold of 50.00.  Percent intact peptide remaining was 
calculated by dividing the area of the parent peptide peak at each time point divided by the area 
of the parent peptide peak at the 0 min time point. The identity of the parent peptide peak was 
confirmed using the parent peptide alone and verified with the t=0 min chromatogram. 
Experiments were performed twice.  
2.2.7 Fluorescent Microscopy 
Adherent HeLa cells were cultured on Falcon Culture Slides (Corning) 24 h prior to 
experimentation. On the day of experiment, the culture media was removed, and the cells were 
washed twice with ECB. 500 µL of a 30 µM peptide solution was incubated with HeLa cells for 
30 minutes at 37°C in the dark. After the incubation period, the peptide solution was removed, 
and the cells were washed twice with ECB to remove excess, unbound peptides. Cells were then 
co-incubated with 4 µM Ethidium homodimer (Life Technologies) and 8 µM Hoechst (Thermo 
Fisher Scientific) stains for 30 minutes and imaged immediately (Figure 2.7). Cellular 
fluorescence was visualized using a Leica DMi8 inverted microscope outfitted with a FITC filter 
cube, 20X objective (Leica HC PL FL L, 0.4X correction), and phase contrast and brightfield 
applications. Digital images were acquired using the Flash 4.0 high speed camera (Hamamatsu) 
with a fixed exposure time of 500 ms for FITC, DAPI, and Rhodamine filters, and 10 ms 
(brightfield). Image acquisition was controlled using the Leica Application Suite software. All 
images were recorded by using the same parameters.  
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A modified protocol was adopted to visualize peptide uptake in four non-adherent cell 
lines: OPM-2, K-526, U-937, and THP-1 (Figure 2.7). For this experiment, a density of 5 x 10
5
 
cells/mL was isolated from T-75 flasks by centrifugation, washed with ECB, and re-suspended in 
a 500 µL solution containing 10 µM peptides. This suspension was incubated at 37°C in 1.5 mL 
microcentrifuge tubes for 60 minutes in the dark. After incubation, the cells were pelleted, the 
peptide solution was removed, and the cells were washed twice with ECB. The cells were then 
re-suspended in ECB and transferred to custom imaging chambers consisting of a silicone o-ring 
(Ace Glass) affixed to a glass coverslip (Corning No 1.4 24x40 mm) using high vacuum grease 
(Dow Corning) and imaged. The surface of the glass coverslip was pre-treated with 7 μL Cell-
Tak (Corning) to attach the cells to the cover glass. The cells were images using the same 
microscope set-up described above. 
An additional microscopy experiment was performed with HeLa cells (Figure 2.8) to 
examine the role of trypsinization after incubating the cells with a peptide solution. For this 
experiment HeLa cells were seeded in a 12-well plate, three days prior to experimentation 
following a protocol previously developed by Qian et al
39
. On the day of experimentation, the 
HeLa cells were washed twice with ECB and incubated with a 10 µM peptide solutions for 60 
minutes at 37°C in the dark. After the incubation period, cells were washed twice with ECB and 
then trypsinized for 10 minutes at room temperature. The cell suspension was transferred from 
the 12-well plate to a 1.5 mL centrifuge tube where the cells were pelleted, and the supernatant 
was removed. The cells were then re-suspended in ECB and then transferred to the custom 
imaging chamber described above coated with CellTak. These cells were then incubated using 
the same microscopy set-up. Both negative control experiments incubating HeLa cells with the 
III-67B peptide and FAM solution were performed using this protocol. 
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2.3 Results and Discussion 
2.3.1 Increasing the Number of Arginine Residues Enhances Cellular Uptake of β-Hairpin 
Protectides 
 
It was hypothesized that the number of positively charged residues on the peptides 
identified by Cline et al
41
 and Houston et al 
44
 could facilitate their behavior as potential CPPs. A 
library of β- hairpin peptides were synthesized using the sequences previously published by 
Houston et al with different amino acid substitutions between ornithine and arginine at positions 
1, 4, and 11 (Figure 2.1 A and Figure 2.2). Ornithine was selected because it is similar in 
structure to lysine, yet was demonstrated to exhibit greater stability
44
. 
 Five iterations of the β-hairpin sequences (RWRWR, RWOWR, OWRWR, OWOWO, 
and WKWK) were found to enter intact HeLa cells (Figure 1B). Uptake of the β-hairpin peptides 
was compared to an unstructured, negative control peptide (III-67B) that was previously 
demonstrated to be rapidly degraded under cytosolic conditions 
44, 46
 and was initially found here 
to be impermeable in intact cells and thus not a CPP. Statistical t-tests were performed against 
this peptide to illustrate the significance of intracellular fluorescent signals for the β-hairpin 
peptides (Figure 1B). The three peptides with at least two arginine residues (RWRWR, 
OWRWR, and RWOWR) demonstrated a rapid, time-independent internalization as assessed by 
F-statistics (Table S1) and reached a statistically significant permeability efficiency compared to 
the negative control peptide within 20 minutes of incubation (Figure 1B).  
Comparing the β-hairpin sequences at the 20-minute time point revealed that the peptide 
with three arginine residues, RWRWR exhibits the highest permeability efficiency (p < 0.0005) 
while the β-hairpin peptides with a single arginine residue (WKWK) or no arginine residues 
(OWOWO) demonstrated the weakest permeability efficiencies (p < 0.005 and p < 0.05).  
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Moreover, these two peptides with one (WKWK) or no arginine (OWOWO) residues 
exhibited slower, time-dependent internalization (Table S1) which required an incubation time of 
 
Figure 2.1. Time-dependent cellular association of β-hairpin protectides with HeLa cells. (A) 
Names and sequences of peptides studied.  Bold amino acids (O-ornithine, R-arginine) at 
positions 1, 4, and 11 were altered for different library members. Substrates were acetylated at 
the N-terminus and amidated at the C-terminus. FAM denotes 5,6-carboxyfluorescein and ‘p’ 
denotes d-Pro. Scrambled, unstructured sequences of the β-hairpins peptides are denoted by an 
‘S’ in the name. (B) 10 μM peptide solution was incubated with intact cells followed by lysis 
and quantification by fluorometry. (C) Comparison between the β-hairpin protectides and two 
commercially-available peptides ARG and TAT. **denotes p < 0.0001 and *denotes p < 0.05 
as compared to the negative control peptide (III67B) to ensure the statistical significance of the 
normalized fluorometry signal for each peptide. P-values correspond to the 20 min time point 
for RWRWR, OWRWR, RWOWR, ARG, and TAT peptides. P-values correspond to the 100 
min time point for OWOWO and WKWK peptides. All data is representative of duplicate 




100 minutes before they reached a significant permeability efficiency against the negative 
control peptide. At the 20-minute time point, RWRWR exhibits a 56-fold increase of 
fluorescence intensity compared to the negative control III67B. OWRWR and RWOWR rank 
second in terms of internalization potential with 49-fold and 42-fold increase in fluorescence 
activity against III67B. The third rank belongs to OWOWO, with a 16-fold increase in 
fluorescence activity against III67B. Finally, WKWK exhibits a 10-fold increase in fluorescence 
intensity against III67B.  
 
Figure 2.2. HPLC trace and mass spectrometry analysis (MALDI-TOF) of the RWRWR 
peptide. (A) HPLC separation was performed with a linear 5% to 55% gradient of solvent B 
(0.1% TFA in acetonitrile) into A (0.1% TFA in water) over 50 min at a 1 mL/min flow rate 
with UV detection at 442 nm. (B) MALDI-TOF of RWRWR peptide yielded an observed 
mass of 1967.067 Da ([M+H]
+
) compared to a calculated mass of 1966.03 Da. 
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At the 100-minute time point, the top performer remains RWRWR, and the rest of the 
peptides perform similarly with fluorescence intensities varying within a small range (Figure 
1B).  These findings are supported by literature with CPPs with a greater number of arginine 
residues exhibiting superior uptake kinetics.
31, 47
  The permeability efficiencies of the β-hairpin 
peptides were then compared to two commercially available CPPs [TAT (FAM-
YGRKKRRQRRR) and ARG (FAM-RRRRRRRRR)]. Both TAT and ARG exhibited better 
permeability efficiency compared to the β-hairpin peptides with TAT showing a one-fold 
increase over RWRWR (p < 0.05) and ARG a two-fold increase over RWRWR (p <0.0001) 
(Figure 1C).  Similar to the observations for the β-hairpin peptides, both TAT and ARG were 
found to exhibit time-independent cellular uptake (Table S1). There are two explanations for the 
enhanced permeability of the TAT and ARG peptides over the members of the β-hairpin library. 
First is the number of arginine residues. TAT has six arginine residues and ARG has nine 
arginine residues compared to three arginine residues in RWRWR. There was a correlation 
between the number of arginine residues and permeability efficiency in the β-hairpins, which 
coincides with the enhanced permeability of ARG over TAT (Figure 1C) which has previously 
been shown in the literature for other arginine-rich peptides.
31, 48, 49
 The second explanation for 




2.3.2 Initial Peptide Concentration, but not Incubation Temperature, Demonstrates a 
Significant Effect on The Permeability Efficiency of β-Hairpin Peptides 
 
The effect of initial peptide concentration and incubation temperature on cellular uptake was 
assessed. All five members of the β-hairpin library were found to enter intact HeLa cells when 
incubated at 4°C, 25°C, or 37°C (Figure 2.3A). A statistical analysis on peptide uptake 
confirmed that incubation temperature did not have a significant effect on the permeability 
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efficiency of any member of the library (Table 2.1).  The fact that decreasing the incubation 
temperature did not inhibit the permeability of the peptides suggests that, in the case of 
endocytosis, the peptides are able to escape the endosome and enter the cytosol.  
 
The absence of any significant effect of incubation temperature on permeability efficiency is 
indicative of the involvement of energy-independent internalization pathways like direct 
membrane transduction at the given experimental conditions. Both endocytosis and energy-
independent internalization have been previously observed in cellular uptake of arginine-rich 
CPPs.
51, 52
. Previous work by Duchardt et al.
51
 revealed that direct membrane transduction was a 
highly efficient, non-disruptive, direct internalization mechanism that occurred at peptide 
concentrations 10 μM and higher. Unlike the direct translocation of CPPs that has been observed 
at concentrations lower than 5 μM, the integrity of the plasma membrane is fully maintained in 
the case of direct membrane transduction. Results discussed here are in line with a recent study 
Table 2.1. ANOVA F-statistics for analysis of the effect of incubation time on peptide 
internalization efficiency. Null hypothesis: μ20 = μ40 = μ60 = μ80 = μ100. ‘μ’ denotes mean 
normalized fluorometry signal reported in Figure 1 and Figure 4 (e.g., there is no significant 
effect of incubation time on the mean signal). Alternate: The signals change with respect to 
time. p< 0.05 rejects the null in favor of the alternate and is considered as evidence for a 
significant effect of incubation time on peptide permeability efficiency, whereas larger p-
values fail to reject the null, and hence demonstrate an insignificant effect of incubation time 
on the signals. Data demonstrates a significant effect of incubation time on the permeability 
of OWOWO, WKWK, and S-RWRWR peptides. The effect of incubation time on the 
permeability of the rest of the peptides is not significant.   
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by Appelbaum, et. al
47
 which demonstrated that discrete arginine arrangements embedded within 
a well-folded protein can result in direct cytosolic access by facilitating both efficient uptake and 
early endosomal escape. 
 
Moving forward, the effect of initial peptide concentration on cellular uptake was 
evaluated. There was a marked increase in peptide uptake in cells incubated with higher initial 
concentrations compared to cells incubated with lower concentration (Figure 2.3 B). 
 
Figure 2.3. Temperature- and concentration-dependent internalization of β-hairpin 
protectides. (A) Intact HeLa cells were incubated with 10 μM peptide solution for 1 h at the 
indicated temperatures in the dark. (B) Intact HeLa cells were incubated for 1 h at 37°C using 
the indicated concentrations of the six peptides. All data is representative of duplicate 
experiments with each data point performed in triplicate to produce the error bars. 
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A statistical analysis of peptide uptake confirmed that initial concentration does have a 
significant effect on the permeability efficiency, although to variable extents (Table 2.2).  The 
effect of concentration was dramatic with the two peptides containing at least two arginine 
residues with one being located at the N-terminus (RWRWR and RWOWR).  Similar results 




One of the peptides with two arginine residues but an N-terminal ornithine residue 
(OWRWR) did show a concentration-dependent increase in uptake; however, this was to a 
slightly lesser extent (Table 2.3, p value less than 0.0005 compared to less than 0.0001). The 
effect of peptide concentration on the permeability efficiency was found to be weak and 
statistically insignificant for the WKWK peptide within the experimental concentration range of 
10 µM to 30 µM. In other words, the uptake of WKWK peptide did not change significantly by 
increasing its concentration above 10 µM. This suggested that the presence of the lysine residues 
Table 2.2. ANOVA F-statistics for analysis of the effect of incubation temperature on peptide 
internalization efficiency. Null hypothesis: μ37 = μ25 = μ4. ‘μ’ denotes mean normalized 
fluorometry signal reported in Figure 2A and Figure S2 (e.g., there is no significant effect of 
incubation temperature on the mean signal). Alternate: The signals change with respect to 
incubation temperature. p< 0.05 rejects the null in favor of the alternate and is considered as 
evidence for a significant effect of incubation temperature on peptide permeability efficiency, 
whereas larger p-values fail to reject the null, and hence demonstrate an insignificant effect of 
incubation temperature on the signals. Data demonstrates that the incubation temperature does 
not have a significant effect on the permeability efficiency of any of the peptides at 10 μM 
concentration and the studied experimental conditions. 
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instead of ornithine and arginine residues as positions 4 and 11 affected the concentration-
dependent uptake within the experimental range.  
 
 
2.3.3 Secondary Structure of β-Hairpin Protectides Reduces Peptide Internalization 
One potential explanation for the enhanced permeability efficiencies of TAT and ARG 
compared to β-hairpin peptides is their lack of secondary structure. To explore this, three 
scrambled peptides were synthesized (S-RWRWR, S-OWRWR, and S-OWOWO) using the 
same amino acids as their structured counterparts, but with these amino acids at different 
positions to eliminate the secondary structure (Figure 1A). Circular dichroism (CD) was used to 
determine the intrinsic structure of the RWRWR and S-RWRWR peptides in addition to the TAT 
peptide (Figure 2.4). The CD spectra of the S-RWRWR and TAT peptides confirmed that they 
were unstructured based on a minimum near 195 nm. Conversely, the CD spectrum of RWRWR 
displayed characteristics of the β-hairpin with a minimum near 205 nm (Figure 2.3). Moreover, 
RWRWR exhibits a maximum near 225 nm that arises from exciton coupling of the indole rings 
Table 2.3. ANOVA F-statistics analysis on the effect of initial peptide concentrations on 
peptide internalization efficiency. Null hypothesis: μ5 = μ10 = μ20 = μ30. ‘μ’ denotes mean 
normalized fluorometry signal reported in Figure 2B (e.g., there is no significant effect of 
initial peptide concentration on the mean signal). Alternate: The signals change with respect 
to initial peptide concentration. P< 0.05 rejects the null in favor of the alternate and is 
considered as evidence for a significant effect of peptide concentration on the permeability 
efficiency, whereas larger p-values fail to reject the null, and hence demonstrate an 
insignificant effect of initial peptide concentration on the signals. Data demonstrates a 
significant effect of initial peptide concentration on the permeability efficiency of all peptides 
except WKWK.  
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of the cross-strand Trp residues, further supporting the correct fold.
53
  These spectra are 











 that have been previously characterized by both NMR and CD 
and shown to adopt a well-folded β-hairpin. 
 
 
The permeability efficiency was quantified for the unstructured, scrambled sequences and 
compared to original structured sequences. All scrambled peptides demonstrated significant 
permeability efficiency against the negative control within 20 minutes of incubation (Figure 2.5). 
The scrambled RWRWR peptide (S-RWRWR) exhibited a superior permeability efficiency 
observable from the 20-minute time point. The signal increased with time and reached over 
three-fold increase in uptake compared to RWRWR at the 100-minute time point (p <0.005). A 
comparison between the uptake efficiency of S-RWRWR and TAT at the 100-minute time point 
showed over one-fold increase in permeability efficiency for S-RWRWR (p <0.001), suggesting 
Figure 2.4. CD spectra of β-hairpin and linear peptides. Experiments were performed using 40 
µM peptide solution in 10 mM sodium phosphate buffer, pH 8.02 at 25°C. The RWRWR 
peptide (black) exhibited spectra associated with a well-folded β-sheet confirmation with a 
minimum near 205 nm. Conversely the S-RWRWR (red) and TAT (blue) peptides were 
determined to be unstructured based on the minimum near 195 nm. 
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that peptide internalization was enhanced by the lack of secondary structure. Similar findings 
have been reported and discussed in the literature suggesting that the incorporation of secondary 
structure such as a β-hairpin in the peptide backbone in an attempt to stabilize a CPP can 
partially compromise their cellular uptake efficiency 
31, 38, 56
 Another interesting finding was that 
the cellular uptake of S-RWRWR was time-dependent with maximal peptide uptake occurring at 
the 100 minute time point. 
 
This contrasts with the RWRWR peptide, which displayed no significant time effect on peptide 
internalization (Table 2.1).  This is an indication of a steady internalization process for S-
RWRWR compared to RWRWR that penetrates the cells rapidly and remains unchanged after 20 
minutes. The S-OWRWR and S-OWOWO peptides did not exhibit any significant time 
dependence in permeability (Table 2.1). Similar to the β-hairpins, no significant temperature 
dependence was observed in the permeability of the scrambled sequences (Figure 2.5, Table 2.2). 
Figure 2.5. Effect of secondary structure on peptide uptake efficiency. ‘S’ peptides refer to 
scrambled sequences of the RWRWR, OWRWR, and OWOWO peptides that lack any 
secondary structure. 10 μM peptide solution was incubated with HeLa at the indicated time 
points. **denotes a p-value < 0.0001 and *denotes a p-value < 0.05. All p-values were 
calculated relative to the negative control peptide III67B. All data is representative of 
duplicate experiments with each data point performed in triplicate to produce the error bars. 
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2.3.4 β-hairpin Protectides Demonstrate Enhanced Stability Under Cytosolic Conditions 
A prior study by Cline et al. demonstrated that the WKWK peptide was highly resistant 
to peptidase-mediated degradation
41
 and a similar study by Houston et al.
44
 confirmed that 
OWRWR exhibited a similar behavior in cell lysates. To investigate the stability of the peptides 
in this study, select peptides were incubated with HeLa lysates to mimic the intracellular 
environment. As expected, the RWRWR peptide was resistant to degradation in HeLa lysates 
(Figure 2.6, black squares) with approximately 80% peptide remaining after 180 minutes 
yielding a half-life of 420 minutes for the intact peptide in the cytosolic mixture. These findings 
match the degradation studies in OPM2 lysates by Houston et al with the OWRWR peptide.
44
 
Conversely, the S-RWRWR peptide was mostly degraded within 120 minutes (Figure 2.6, red 
circles) with a half-life of 30 minutes. 
 
Figure 2.6. Analysis of peptide degradation in HeLa lysates using RP-HPLC. The stability 
of the structured, unstructured, and commercially-available peptides was evaluated by 
incubation with 2 mg/mL HeLa lysates at 37°C. The structured β-hairpin RWRWR (black 
squares, t1/2=423.08 min) was substantially more resistant to degradation than its 
unstructured counterpart S-RWRWR (red circles, t1/2=27.9 min) as evidenced by a 
substantially greater amount of intact peptide and a significantly higher half-life. The 
commercially-available TAT peptide exhibited rapid degradation in the HeLa lysates (green 
triangle, t1/2=10.0 min). An unstructured, rapidly degraded peptide (III-67B) was used as a 
positive control to demonstrate the activity of the HeLa lysates (inverted blue triangles, 
t1/2=9.5 min). The zero-minute time point was achieved using heat shocked lysates and 
served as the baseline for intact peptide.  
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Thus, the secondary structure present in RWRWR resulted in an increase in stability 
compared to its unstructured counterpart. It was found that TAT was mostly degraded within 30 
minutes (Figure 2.6, blue triangles) with a half-life of 10 minutes. The stability of TAT was 
comparable to the unstructured negative control peptide, III-67B, which was previously found to 
rapidly degrade under cytosolic conditions.
44
 In this study, III-67B (Figure 2.6, green triangles) 
displayed a half-life of 9.5 minutes, similar to that found by Houston et al. 
 These findings indicate that while the presence of secondary structure in a CPP can 
decrease the permeability efficiency, it will increase the stability of the peptide once it gains 
entry into intact cells. These findings are consistent with previous observations for stable CPPs 




 or cyclic structures
50, 58, 59
. 
2.3.5 Cellular Distribution of Internalized β-Hairpin Peptides in Model Cancer Cell Lines 
Live cell microcopy studies were performed to provide further evidence of the 
internalization of the β-hairpin peptides. HeLa cells, previously seeded on microscopy glass 
slides, were incubated with the RWRWR and OWRWR peptides and immediately visualized to 
show the intracellular peptide distribution in intact cells while preserving the intact cell 
morphology (Figure 2.7). Cell nuclei were co-stained with Hoechst, and viability was assessed 
using Ethidium homodimer-1 (Eth-D1). The absence of any signal from the Eth-D1 confirmed 
the absence of any dead cells and cell debris in the images and therefore the viability of cells 
after incubation with peptides at a concentration as high as 30 µM.  A negative control was 
performed incubating cells with extracellular buffer (no peptide) to confirm the intracellular 
fluorescence was due to the CPPs (Figure 2.7). It was observed that the RWRWR and OWRWR 
peptides were distributed across the cytosol and nucleus of HeLa cells in a heterogenous manner 
in terms of both intracellular peptide distribution and cell-to-cell variability. These results 
32 
suggest that there is an inherent heterogeneity in cellular uptake with select cells showing greater 
peptide uptake than others. These findings are in line with current efforts in single cell analysis 
of cancer cells
27, 46, 60
 and will be investigated in future studies using high-throughput single cell 
screening methods. Nevertheless, these results confirm that the β-hairpin sequences introduced 
here can enter intact cells and exhibit cytosolic and nuclear distribution within the cell while 
maintaining cell viability. 
  
 
An additional microscopy experiment was performed to investigate the role of 
trypsinization prior to imaging the cells using fluorescent microscopy to determine if the 
trypsinization step altered peptide uptake (Figure 2.8). HeLa cells were incubated with four 
Figure 2.7. Intracellular distribution of β-hairpin peptides in HeLa cells. 30 µM RWRWR 
and OWRWR peptide solutions were incubated with HeLa cells seeded on glass imaging 
chambers for 30 minutes at 37°C. Cells were washed with ECB and co-incubated with 4 µM 
Ethidium homodimer-1 (Eth-D1) and 8 µM Hoechst stain for 30 minutes prior to imaging. 
Bottom row shows illustrates cells incubated with only ECB as the negative (no peptide) 
control. Representative images include brightfield, Rhodamine (Eth-D1), FITC (for peptide 
uptake), and DAPI (Hoechst) filters. All scale bars are 40 μm. 
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FAM-labeled peptides (RWRWR, OWRWR, TAT, and ARG) for 60 min at 37°C and then 
trypsinized after the incubation period, prior to imaging, to remove any peptide bound to the 
outside of the cell as an additional control. It has been previously reported in the literature that 
trypsin removes cell-surface bound proteins without affecting internalized peptides.
47
 Similar 
results of peptide uptake were observed in HeLa cells including or removing a trypsinization step 
prior to imaging. It was observed that the fluorescent signal was distributed across the cells 
treated with both RWRWR and OWRWR indicating cytoplasmic and nuclear distribution of the 
peptide (Figure 2.8 A-B). A similar result was observed for cells treated with the positive 
controls TAT and ARG (Figure 2.8 C-D). Control experiments were performed treating the cells 
with the non-permeable III-67B peptide and the fluorophore FAM which showed no observable 
increase in fluorescent signal confirming that the negative control peptide and the fluorophore 
alone were not capable of cellular entry (Figure 2.8 E-F). 
  
Figure 2.8. Live-cell microscopy images of HeLa cells treated with FAM-labeled CPPs. 10 
μM solutions of (A) RWRWR, (B) OWRWR, (C) TAT, (D) ARG, (E) III-67B, and (F) 
FAM were incubated with intact HeLa cells for 60 minutes at 37°C. Representative images 
of HeLa cells using brightfield (left) and FITC (right) filters. All scale bars are 40 μm. 
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Control experiments containing no peptide were performed along with every microscopy 
experiment that resulted in no observable fluorescent signal.  The uptake of the RWRWR peptide 
was also assessed in four non-adherent cancer cell lines. 10 μM RWRWR peptide solutions were 
incubated with a multiple myeloma cell line (OPM2), a lymphoma cell line (U937), an acute 
monocytic leukemia cell line (THP-1), and a chronic myelogenous leukemia cell line (K562) as 
shown in Figure 2.7. All non-adherent cell lines showed prominent cellular uptake of the 
RWRWR peptide; however, the localization within the cell varied. An evenly distributed 
fluorescent signal was observed in OPM2, K562, and U937 cells while punctuate fluorescence 
was observed in the THP-1 cells. This confirms that the β-hairpin peptides can gain entry to non-
adherent cell lines as well as adherent cell lines. 
 
 
Figure 2.9.  β-hairpin peptide cellular internalization in suspension cancer cell lines. 10 
μM RWRWR peptide solutions were incubated with four non-adherent cancer cell lines 
including OPM2, U937, THP-1, and K562 for 60 minutes at 37°C. Cells were attached 
to cover glass using CellTak prior to imaging. Representative images include brightfield 




With the increased use of peptide-based reporters in addition to coupling CPPs with 
peptide and small molecule drugs, there is a great need to identify new classes of cell penetrating 
peptides with enhanced intracellular stability. This work identified that peptides with a β-hairpin 
sequence motif functioned as CPPs while simultaneously behaving a long-lived protectides. The 
cellular uptake of three of β-hairpin peptides (RWRWR, OWRWR, and RWOWR) was found to 
be time-independent above 10 minutes of incubation, while the uptake of all five peptides was 
found to be temperature-independent. However initial concentration did affect peptide uptake in 
the peptides with two or more arginine residues. It was determined that the number of arginine 
residues present in the peptide correlates with optimal permeability efficiency of the β-hairpin 
peptides, with the RWRWR peptide displaying the best permeability efficiency. A comparison 
between the structured β-hairpin peptides, unstructured scrambled sequences, and unstructured 
commercially available CPPs (TAT and ARG) indicated that the presence of a secondary 
structure decreases the cellular uptake of the peptides. However, the secondary structure confers 
an increase in peptide stability. Thus, there exists a tradeoff between uptake kinetics and 
intracellular stability of CPPs which has been demonstrated in the literature and now includes 
peptides with secondary structure to those with D-amino acids and β-amino acids
31, 34, 35, 57, 59
.  
The superior intracellular stability of the β-hairpin peptides makes them ideal candidates for 
peptide-based reporters or PROTAC-based therapeutics that require long-lived peptides. Live 
cell microscopy images visualized peptide localization in cytosol of intact cells and confirmed 
cell viability. The degree of peptide uptake across the population of cells was found to be 
heterogeneous both in terms of cell to cell variability and intracellular peptide distribution. Work 
is currently underway to further investigate this phenomenon by performing high-throughput 
36 
single cell analysis of CPP uptake in intact cells. These future studies aim to provide a greater 
understanding of CPP uptake efficiency and intracellular peptide homogeneity in addition to 























Chapter 3: Uptake Kinetics of Protease-Resistant, D-Chirality Cell 
Penetrating Peptides in Mammalian Cells 
3.1 Introduction 
Cell penetrating peptides (CPPs) are powerful tools for delivering bioactive cargo into the 
cytosol of intact cells for therapeutic and sensing purposes
31
. One limitation of many CPPs is 
their rapid degradation under cytosolic conditions which limits their application in 
pharmaceutical and biomedical research due to the failed delivery of  drugs or biosensors
35
. 
Therefore, there is a need to develop CPPs with enhanced protease resistance which can be 
incorporated into intracellular biosensors for performing long-term dynamic studies in single 
intact cells
46
. Common strategies for developing protease-resistant CPPs were discussed in above 
which include incorporating D-chirality amino acids
33
 into the sequence or utilizing secondary 
structure in the backbone of peptides. In Chapter 2, a library of β-hairpin short sequence motif 
protectides were characterized as cell penetrating peptides with enhanced intracellular stability
61
. 
It was found that incorporating a β-hairpin secondary structure into peptide enhanced 
intracellular stability; however, it decreased peptide uptake efficiency leading to a trade-off 
between peptide stability and uptake efficiency. This was a common finding in the literature that 
the incorporation of secondary structure such as a β-hairpin or a cyclic motif into the peptide led 
to a decrease in cellular uptake efficiency
31, 38, 56
. In recent years, significant effort has been 
devoted to developing cell penetrating peptides that demonstrate enhanced intracellular stability 
while maintaining superior internalization efficiency
30
. Prior work presented in Chapter 2 found 
that linear, scrambled sequences of the β-hairpin peptides were found to exhibit enhanced uptake 
efficiencies over their structured counterparts. In this chapter, the incorporation of D-chirality 
amino acids into the linear, scrambled sequences identified in Chapter 2 was explored as an 
approach to enhance intracellular stability while maintaining CPP uptake efficiencies. This was 
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accomplished by modifying the S-OWRWR, S-RWRWR, and S-RWOWR sequences (Figure 
2.1) by altering the stereochemistry of amino acid residues from L to D-chirality. Peptides were 
characterized using a similar approach to what was discussed in Chapter 2 in terms of 
internalization efficiency and intracellular stability. Peptide internalization was quantified in 
HeLa cells using fluorometry and visualized by fluorescent microscopy. Interestingly, D-
chirality peptides demonstrated rapid uptake in intact cells which was found to be superior to all 
the peptides presented in Chapter 2 including the commercially available TAT and ARG and the 
L-chirality versions of the same sequences. This result identified a preferential uptake of D- 
versus L-chirality amino acid CPPs in HeLa cells. As expected, degradation studies in HeLa 
lysates demonstrated high peptide stability under cytosolic conditions. Despite these findings, the 
D-chirality peptides were observed to be expelled from intact cells after 10 min as demonstrated 
by a time-dependent decrease in intracellular fluorescence. It was hypothesized that D-chirality 
peptides were expelled by the cells via an extrinsic mechanism after being internalized. This is a 
phenomenon that was previously described and characterized for Poly(D,L-Lactide-co-
Glycolide) (PLGA) nanoparticles in vascular smooth muscle cells
21
; but has not been described 
for D-chirality CPPs. Development of cell penetrating peptides as efficient delivery vectors for 
intracellular drugs or biosensors would depend on their permeability efficiency, intracellular 
stability, and retention in the cells. Therefore, it is important to investigate the presence of such 
export mechanisms for non-natural sequences and characterize them. Experiments were 
performed to characterize the energy-dependent removal of D-chirality peptides from intact 
HeLa cells. It was found that the expulsion of the D-chirality peptides from cells decreased at 
lower temperatures but increased in presence of serum which confirms the mechanism for 
expulsion was energy dependent. Current efforts are underway to identify the biochemical 
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pathways involved in this process using the exocytosis inhibitor EXO1. These findings have 
several implications with respect to drug and biosensor delivery into intact cells considering the 
potential of incorporating D-chirality amino acids in CPPs as a strategy to confer protease 
resilience to them. 
3.2 Materials and Methods 
3.2.1 Chemicals 
Fmoc-protected amino acids, 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3 - 
tetramethylaminium hexafluorophosphate (HCTU), trifluoroacetic acid (TFA) and rink amide SS 





allyloxycarbonyl-L-ornithine (Fmoc-Orn(Aloc)-OH) was purchased from Chem-Impex 
International, Inc, Wood Dale, IL. 1-Hydroxy-6-(trifluoromethyl)benzotriazole (HOBt) and 
(Ethyl cyano(hydroxyimino)acetato)-tri-(1-pyrrolidinyl)-phosphonium (PyBOP) were purchased 
from Novabiochem, Billerica, MA. Dimethylformamide (DMF) was purchased from Protein 
Technologies, Tucson, AZ.   Diisopropylethylamine (DIEA), triisopropylsilane (TIPS) 
tetrakis(triphenylphosphine) palladium (0) (palladium), 5(6)-carboxyfluorescein (FAM), 
chloroform (CHCl3), methanol (MeOH), dichloromethane (DCM), and N-methylmorpholine 
(NMM) were purchased from Sigma Aldrich, St. Louis, MO.  Glacial acetic acid was purchased 
from Alfa Aesar, Ward Hill, MA. Acetic anhydride was purchased from Fisher Scientific, Fair 
Lawn, NJ. 
3.2.2 Peptide Synthesis and Purification 
The peptides were synthesized on a Tribute peptide synthesizer (Protein Technologies, 
Tucson, AZ) utilizing a standard Fmoc peptide chemistry protocol on a 100 µmol scale using 
rink amide resin (189 mg, 0.53 mmol/g).  Five-fold excess of Fmoc-amino acids (Fmoc-d-
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Arg(Pbf)-OH, Fmoc-d-Trp(Boc)-OH, Fmoc-d-Val-OH, Fmoc-d-Pro-OH, Fmoc-Gly-OH, Fmoc-
d-Ile-OH, Fmoc-d-Gln(Trt)-OH, Fmoc-d-Orn(Boc)-OH, Fmoc-Orn(Aloc)-OH), and HCTU, in 
the presence of 10 equivalents of NMM were used for each of the amino acid coupling steps (10 
min) with DMF as the solvent.  A solution of acetic anhydride, NMM and NMP (1:1:3) was 
added to the Fmoc-deprotected resin and shaken for 30 minutes to acetylate the N-terminus of 
the peptide.  Once the peptide synthesis was complete, the resin was washed with DMF (3x30 
sec) then DCM (3x30 sec).  The Aloc group was removed with three-fold excess of palladium in 
4 ml of CHCl3-HOAc-NMM (37:2:1) under nitrogen for 2 hrs.  The resin was then washed with 
DCM (3x30 sec) followed by DMF (3x30 sec).  In the dark, FAM was coupled to the delta 
nitrogen of the ornithine side chain with four-fold excess of FAM, HOBt, PyBOP and DIEA in 
3mL DMF for 24 hrs and then repeated for 8 hours.  The peptide resin was washed with DMF 
(3x30 sec) and DCM (3x30 sec).  
The peptide was cleaved from the resin and side-chain deprotected using 
TFA/water/TIPS (4 mL, 95:2.5:2.5) for 3 hours and collected in a 50 mL centrifuge tube.  The 
cleavage reaction was repeated for 10 minutes. The cleavage solutions for the peptide were 
combined and concentrated in vacuo.  Cold diethyl ether was then added to the peptide solution 
to precipitate the crude peptide.  The peptide was centrifuged for 10 minutes (4,000 rpm) and the 
ether layer decanted.  Fresh cold diethyl ether was added and the pelleted peptide was 
resuspended.  The peptide was centrifuged again and the procedure was repeated 5 times in total.  
After the final ether wash, the peptide pellet was dissolved in 5 mL water containing 0.1% TFA, 
frozen and lyophilized.   
HPLC analysis was performed with a Waters 616 pump, Waters 2707 Autosampler, and 996 
Photodiode Assay Detector which are controlled by Waters Empower 2 software. The separation 
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was performed on an Agilent Zorbax 300 SB-C18 (5 um, 4.6 x 250 mm) with an Agilent guard 
column Zorbax 300 SB-C18 (5 um, 4.6 x 12.5 mm).  Elution was done with a linear 5% to 55% 
gradient of solvent B (0.1% TFA in acetonitrile) into A (0.1% TFA in water) over 50 min at a 1 
mL/min flow rate with UV detection at 442 nm.  Preparative HPLC runs were performed with a 
Waters prep LC Controller, Waters Sample Injector, and 2489 UV/Visible Detector which are 
controlled by Waters Empower 2 software. The separation was performed on a Agilent Zorbax 
300SB-C18 PrepHT column (7 um, 21.2× 250 mm) with Zorbax 300SB-C18 PrepHT guard 
column (7 um 21.2 × 10 mm) using a linear 5% to 55% gradient of solvent B (0.1% TFA in 
acetonitrile) into A (0.1% TFA in water) over 50 min at a 20 mL/min flow rate with UV 
detection at 215 nm.  Fractions of high (>95%) HPLC purity of each peptide and with the 
expected mass were combined and lyophilized. 
3.2.3 Cell Culture and Lysate Generation 
Methods in this section were the same as Chapter 2.2.3. 
3.2.4 Quantification of Peptide Cell Permeability 
Methods for time-, concentration-, and temperature-dependent cell permeability assays 
were the same as chapter 2.2.4.  
3.2.5 Evaluation of D-Chirality Peptide Export from Cells 
A modified version of the experimental protocol was performed to study peptide export 
from cells after internalization. To accomplish this, 30 µM DS-rwrwr peptide was incubated with 
intact HeLa cells previously seeded on 12-well plates, as previously described in Chapter 2.3.4 
for 10 min at 37°C in the dark. After the incubation period, the peptide solution was removed, 
and the cells were washed twice with ECB. Fresh ECB was added to the cells which were further 
incubated at in the dark for the indicated incubation times to study peptide export rates. Samples 
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that were lysed immediately (using the methods explained in Chapter 2.3.4) after peptide 
removal were marked as the 0 min time point in terms of peptide export. Peptide expulsion 
samples were separated into three different groups. The first two cohorts w incubated at 37°C 
with ECB in prescence and absence of 5% serum. The third cohort was incubated at 4°C in the 
absence of serum. At the indicated times, the cells were trypsinized, lysed, and transferred to a 
96-well plate using the methods explained in Chapter 2.3.4. Normalized fluorescence ratios were 
calculated by dividing the signal measured for each time point by the zero-min time point. 
3.2.6 Circular Dichroism 
Methods in this section were the same as Chapter 2.3.5. 
3.2.7 Peptide Degradation Studies 
Methods in this section were the same as Chapter 2.3.6. 
3.2.8 Fluorescent Microscopy 
Fluorescent microscopy, Hoechst staining and Ethidium homodimer staining were 
performed using the same methods as Chapter 2.3.7. 
3.3 Results and Discussion 
3.3.1 D-Chirality Peptides Demonstrate Rapid Cellular Uptake and Superior Permeability 
Efficiency over Their L-Chirality Counterparts  
 
Three D-chirality peptides based on the scrambled sequences of β-hairpins (herein 
referred to as DS peptides) were synthesized and characterized in terms of cell permeability 
efficiency (Table 3.1, lower case letters denote D-chirality). All three DS peptides demonstrated 
rapid internalization in HeLa cells after incubation for 10 min at 37°C and a significant increase 
in cell permeability efficiency compared to the four positive control peptides (TAT, ARG, S-
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RWRWR, and S-OWRWR) (Figure 3.1). The D-chirality variant of S-RWRWR (DS-rwrwr) was 
found to be the top performer followed by the D-chirality variants of S-RWOWR (DS-rwowr) 
and S-OWRWR (DS-owrwr). The uptake of DS-rwrwr peptide demonstrated a 20-fold increase 
in permeability efficiency compared to the top performing positive control (ARG) identified in 
Chapter 2 (Figure 2.1C). 
 
These results identified a preferential uptake of D- versus L-chirality CPPs in HeLa cells 
which contradicts a previous work by Verdumen et. al.
62
 This study previously reported that 
cationic L-CPPs were taken up more efficiently than their D-counterparts in MC57 fibrosarcoma 
and HeLa cells, but not in Jurkat T leukemia cells. 
 
Table 3.1 Library of D-chirality peptides. Names and sequences of peptides studied.  
Substrates were acetylated at the N-terminus and amidated at the C-terminus. FAM denotes 
5,6-carboxyfluorescein. 
Figure 3.1. Cell permeability efficiency of library of D-chirality peptides 10 μM peptide 
solution was incubated with intact cells followed by lysis and quantification by fluorometry. 
Comparison between the L-chirality scrambled peptides and two commercially-available 
peptides ARG and TAT All data is representative of duplicate experiments with each data 
point performed in triplicate to produce the error bars. 
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The internalization capacities of the D-chirality peptides were strongly concentration 
dependent (Figure 3.2). This is similar to the results observed for the peptides studied in Chapter 
2 and previous studies on TAT and ARG peptides
51, 52
. Similarly, the effect of concentration was 
more pronounced with peptides containing an N-terminal arginine residue which may be 
attributed to the activation of different internalization pathways for those peptides. 
 
3.3.2 D-Chirality Peptides Demonstrate Enhanced Stability Under Cytosolic Conditions 
Circular dichroism (CD) was used to determine the structure of the DS-owrwr and S-
OWRWR peptides (Figure 3.3). The CD spectra of DS-owrwr demonstrated maximum near 196 
nm, while the linear, L-chirality S-OWRWR peptide exhibited a minimum near 200. A similar 
minimum was observed for a known unstructured control peptide (III67B) used as control. As 
expected, the profile of DS-owrwr was reflected across the zero-line due to its preferential 
Figure 3.2 Concentration dependence cell permeability Peptides at varying concentrations 
were incubated with HeLa cells for 60 minutes at 37 °C. A strong concentration dependence 
is observed for peptide uptake efficiency. 
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absorbance for right circularity polarized (RCP) versus left circularity polarized (LCP) light. 
This spectrum was close to the mirror image of that of S-OWRWR which confirms these 
sequences are enantiomers. These results are consistent with findings in Chapter 2 which 
illustrate the lack of secondary structure in both the L- and D-chirality peptides. 
 
A prominent feature of D-chirality peptides is their enhanced resistance to intracellular 
degradation
33
. To confirm that the D-chirality peptide DS-rwrwr exhibited a similar behavior, its 
stability was assessed using the degradation assay described above. As illustrated in Figure 3.4, 
~80% of the DS-rwrwr peptide remained after a 3-hour incubation period with HeLa lysates. The 
approximate half-life for DS-rwrwr was calculated to be 543 min, which was slightly higher than 
the structured, β-hairpin RWRWR (t1/2=423 min) and demonstrated a 20-fold increase compared 
Figure 3.3. CD spectra of D-chirality and L-chirality peptides. Experiments were performed 
using 40 µM peptide solution in 10 mM sodium phosphate buffer, pH 8.02 at 25°C. The DS-
owrwr peptide (black) a maximum near 196 nm. Conversely the S-OWRWR (blue) and 
III67B (red) peptides were determined to be unstructured with an L-chirality based on the 




to the L-chirality, linear peptides TAT (t1/2=10 min) and S-RWRWR (t1/2=28 min) described in 
Chapter 2. These results confirm the stability of DS-rwrwr due to altering the chirality of amino 
acids. Moreover, this confirmed the hypothesis that D-chirality substitutions could increase the 
stability of the CPP while maintaining the enhanced uptake efficiency of linear sequences. 
Similar results regarding the intracellular stability of D-chirality peptides have been previously 





Figure 3.4. Analysis of peptide degradation in HeLa lysates using RP-HPLC. The stability 
of the DS-rwrwr peptide was evaluated by incubation with 2 mg/mL HeLa lysates at 37°C. 
The zero-minute time point was achieved using heat shocked lysates and served as the 
baseline for intact peptide. 80 percent of the peptide was retained in cell lysates after the 180 




3.3.3 Time-Dependent Permeability Studies Reveal D-Chirality Peptides are Expelled from 
Cells 
 
The time-dependence of the internalization process of the peptides was evaluated by 
incubating 10 µM peptide solutions with HeLa cells for incubation times up to 120 min at 37 °C 
in the dark. Surprisingly, this study found that DS peptide uptake significantly diminished over 
time (Figure3.5) This observation was not expected due the pronounced intracellular stability of 
the DS-peptides coupled with prior findings on the sustained uptake of the linear, L-chirality 
peptides (Chapter 2). 
 
A comparison was performed between the β-hairpin sequences, the L-chirality, scrambled 
peptides and the D-chirality scrambled peptides (Figure 3.6). It was found in Chapter 2 that the 
internalization efficiency of the S-RWRWR peptide was positively correlated to the incubation 
Figure 3.5. Time-dependent analysis of uptake of D-chirality peptides 10 μM peptide 
solution was incubated with intact cells for varying periods of time followed by lysis and 
quantification by fluorometry. A consistent decay of fluorescent outputs was observed. 
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time (Figure 2.1 B). Conversely, the other two scrambled sequences (S-OWRWR and S-
OWOWO) demonstrated rapid uptake within 10 minutes followed by a sustained fluorescent 
signal at longer incubation times. Similarly, the commercially available TAT and ARG peptides 
also demonstrated rapid uptake within 10 minutes and constant signals beyond that period 
(Figure 2.1 C). Even though the DS peptides exhibited lowered internalization potential at 
incubation times greater than 10 min, the amount of DS-rwrwr that was internalized after 80 min 
was similar to the uptake of the ARG peptide after 80 min. It was hypothesized that the decrease 
in fluorescent signals measured for the DS peptides is due to peptide expulsion and not peptide 
degradation since the intracellular stability of the peptides was confirmed in Chapter 3.3.2.  
 
Figure 3.6. Time-dependent analysis of peptide uptake 10 μM peptide solution was 
incubated with intact cells for varying periods of time followed by lysis and quantification 
by fluorometry. A consistent decay of fluorescent outputs was observed. 
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3.3.4 D-chirality Peptides Are Expelled from Cells via an Energy-Dependent Export 
Mechanism 
To investigate the diminished uptake of DS peptides in cells over time, HeLa cells were 
incubated with 10 µM peptide solutions at varying temperatures (37, 25, and 4°C) to evaluate the 
role of temperature on peptide internalization and expulsion. As illustrated in Figure 3.7, the 
permeability efficiency of DS-rwrwr was enhanced by decreasing the incubation temperature to 
4 °C. Conversely, the uptake of DS-owrwr was unchanged in HeLa cells incubated at lower 
temperatures. Uptake of DS-rwowr was reduced by decreasing the incubation temperature from 
37°C to 25°C; however, a further reduction the incubation temperature to 4°C did not affect 
peptide uptake. These findings were in stark contrast to prior studies examining the role of 




Figure 3.7. Temperature- and concentration-dependent internalization of D-chirality peptides. 
(A) Intact HeLa cells were incubated with 10 μM peptide solution for 1 h at the indicated 
temperatures in the dark. Results are representative of several experiments with each 
datapoint repeated in triplicate to produce the error bars. 
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 These findings (outlined in Chapter 2) concluded that incubation temperature did not 
have any significant effect on the level of peptide internalization (Figure 2.3 A). This suggested 
that the difference in internalization and retention of the peptides due to the different chirality 
could be attributed to the competition between the intrinsic and extrinsic mechanisms leading to 
peptide uptake and expulsion from the cells, with temperature being an important factor in the 
final net amount of internalized peptide.  The increase in DS-rwrwr peptide content in cells 
incubated at lower temperatures suggests that the expulsion of the D-chirality peptide is due to 
an energy-dependent process which is diminished at lower temperatures. To further investigate 
this, an alternate experiment was performed where the peptide solution was removed after 10 
minutes of incubation at 37 °C to halt the influx of additional peptide into the cells and solely 
examine peptide expulsion. After the removal of the peptide solution, the cells incubated in fresh 
ECB in presence or absence of serum at 37 °C, and in absence of serum at 4 °C and then 
analyzed to study the dynamics of the peptide export process. Results of this study (Figure 3.8) 
revealed that the expulsion of DS-rwrwr from HeLa cell was diminished at a lower temperature 
while it was enhanced by supplementing the cells with 5% serum. This suggested that D-chirality 
peptide expulsion was an energy-dependent process which could be enhanced by the presence of 
serum or diminished by maintaining the cells at lower temperatures following an initial uptake 
period. Thus, the peptide internalization and export mechanisms were both found to be dynamic 
and occurring simultaneously with the export mechanism confirmed to be an active mechanism 
due to its energy-dependence. Similar results were previously reported by Panyam and 
Labhasetwar that characterized the endocytosis and exocytosis of Poly(D,L-Lactide-co-
Glycolide) nanoparticles in vascular smooth muscle cells
21
. They also identified a dynamic, 
energy-dependent pathway expelling the nanoparticles from the cells. It is suspected that the D-
51 
chirality peptides were recognized as non-natrual by the cells which utilized an energy-
dependent pathway like exocytosis to expel them. Current efforts are underway to characterize 




3.3.5 Visualization of Peptide Distribution in Intact Cells by Fluorescent Microscopy 
Live cell microcopy studies were performed to provide further evidence of the 
internalization of the D-chirality peptides. HeLa cells were incubated with a 30 µM solution of 
DS-rwrwr 10 min and immediately visualized to show the intracellular peptide distribution in 
intact cells while preserving the intact cell morphology (Figure 3.9). A uniform distribution of 
peptide was observed in the majority of the cells. To investigate the effect of the D-chirality 
peptides on cell viability, an additional experiment was performed where cell nuclei were co-
stained with Hoechst and viability was assessed using Ethidium homodimer-1 (Eth-D1) (Figure 
Figure 3.8. Energy dependence of peptide expulsion. Intact HeLa cells were incubated with 
10 μM peptide solution for 10 minutes at 37 °C. Peptides were removed, cells were washed 
with and incubated with fresh ECB at 37 C in presence and absence of 5% Fetal Bovine 
Serum (FBS) and at 4 C in absence of serum. Cells analyzed immediately after peptide 
removal marked the 0-min time point. Signals obtained for the rest of the time points were 
divided by the 0-min signals to calculate the normalized fluorescence ratios. 
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3.10). The absence of any signal from the Eth-D1 confirmed the lack of any dead cells and cell 
debris in the images and therefore the viability of cells after incubation with peptides at a high 
concentration (30 µM) followed by peptide internalization.  
 
 
This confirmed that the D-chirality peptides did not result in a decrease of cellular 
viability; however, this study provided further evidence of peptide expulsion over time. The 30 
min incubation period needed for viability and nuclear staining provided sufficient time for the 
internalized peptide to be expelled from the cells.  
 
 
Figure 3.9. Intracellular distribution of D-chirality peptides in HeLa cells. A 30 µM DS-
rwrwr peptide solution was incubated with HeLa cells seeded on glass imaging chambers for 
10 minutes at 37°C. Cells were washed with ECB and immediately visualized using 
brightfield and FITC filters. Scale bar is 40 μm. 
 
 
Figure 3.10. Intracellular distribution of D-chirality peptides in HeLa cells. A 30 µM DS-
rwrwr peptide solution was incubated with HeLa cells seeded on glass imaging chambers for 
10 minutes at 37°C. Cells were washed with ECB and further co-incubated with Hoechst and 
Eth-D1 stains diluted in sodium phosphate buffer for 30 minutes at 37 °C and visualized 
using brightfield(cells), FITC (peptide), DAPI(Hoechst), and Rhodamine (dead cells) filters. 




This can be concluded based on the findings from Figure 3.9 when the cells were immediately 
imaged after incubating the HeLa cells with the peptide, further confirming D-chirality peptide 
expulsion from the intact cells. 
3.4 Conclusions 
A small library of peptides with D-chirality amino acid residues were designed and 
synthesized based on linear, scrambled sequences of β-hairpins. The structures of the D-chirality 
peptides were confirmed by CD and the enhanced stability was validated using a degradation 
assay and HPLC. All three D-chirality peptides (DS-rwrwr, DS-rwowr, and DS-owrwr) 
demonstrated rapid uptake in intact HeLa cells with superior permeability efficiencies over 
commercially available L-chirality peptides TAT and ARG after 10 min of incubation. 
Additionally, the L-chirality versions of the same sequences (S-RWRWR and S-OWRWR, see 
Chapter 2) were found to exhibit decreased uptake when compared to their D-chirality 
counterparts
61
. As such, altering the chirality of the peptides from L to D increased their 
internalization efficiencies by 20-fold over previously identified CPPs ARG and S-RWRWR. 
The internalization of the D-chirality peptides was found to be highly concentration dependent, 
similar to what was observed for the L-chirality peptides. Time- and temperature-dependent 
permeability assays indicated that the D-chirality peptides were exported from the intact cells in 
an energy-dependent manner after being internalized. This export mechanism was similar to 
findings previously described in the literature for PLGA nanoparticles;
21
 but has not been 
described for D-chirality CPPs. As such, the cellular export mechanism in currently unknown. 
However, the findings here indicated that this mechanism is energy-dependent as peptide 
expulsion was diminished by decreasing the incubation temperature but increased in the presence 
of serum. Current work is underway to investigate this mechanism using an inhibitor (EXO1). 
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Considering the application of incorporating D-chirality amino acids in CPPs as a strategy to 
confer protease resilience to cell penetrating peptides, the findings from this study has merit in a 
number of applications ranging from drug delivery to biosensing motivating a need for further 
















Chapter 4: Population-Based Analysis of Cell Penetrating Peptide Uptake 
Using a Microfluidic Droplet Trapping Array 
4.1 Introduction 
Due to the abundance of pharmaceuticals designed to target intracellular proteins, 
efficient methods to deliver drugs, vectors, and biosensors into intact cells  has gained 
tremendous attention in recent years.
23
 Examples include small molecule inhibitors used as 
chemotherapeutics for treating cancer and other human diseases, silencing RNA, and biosensors 
for measuring the activity of intracellular enzymes
24, 27, 28
. Cell penetrating peptides (CPPs) are 
powerful delivery tools that can traverse the plasma membrane of intact cells without disrupting 
membrane integrity to deliver different types of cargoes to the cytosol to perform important 
functions
23, 24, 28
. These synthetic sequences are especially advantageous due to their ease of 
synthesis and use, high efficiency and low cytotoxicity to cells, and compatibility with small 
sample sizes and high-throughput screening methods
31
 .  
Characterizing the uptake efficiency, intracellular distribution, cytotoxicity, and uptake 
mechanism of CPPs is of utmost importance due to their direct relevance to clinical applications 
for drug delivery and point of care personalized diagnostics.
31, 51
 Significant efforts have focused 
on developing new CPPs that increase uptake efficiency with enhanced intracellular stability and 
minimized cytotoxicity to the cells
30, 33, 41
 which is in direct correlation with their uptake 
mechanism 
26
. However, most of these studies  utilized static bulk measurements of samples, 
which cannot capture the heterogeneous nature of cells, especially cancer cells, which could 
result in some of these studies being misleading
63
. In most cases, population heterogeneity 
manifests itself in non-normal distributions
63
 in which case the mean value of the blended 
responses is a poor representative of the entire population, and therefore fails to accurately 
describe the population behavior. For this reason, there have been substantial efforts to analyze a 
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large number of individual cells and obtain population distributions
64, 65
 to better describe and 
predict the behavior of cell populations and address the heterogeneity associated with them. 
Traditionally, the gold standard for performing single cell analysis has been flow cytometry;
63, 66
 
however, it is limited to static measurements. This limitation has been overcome by using laser 
scanning cytometry which allows for scanning a single cell over time, but its throughput is lower 
than flow cytometry and it is still limited to whole cell responses, and therefore fails to 
characterize the intracellular events
63
.  
In recent years, microfluidics have revolutionized the state of single cell analysis by 
facilitating high-throughput screening of therapeutic-level quantities of cells using minute 
sample sizes which is made possible due to the micron level sizes of flow channels in 
microfluidic devices 
67
. Droplet microfluidics, which operate through generating picolitre-sized 
droplets in an immiscible continuous oil flow, have allowed researchers to perform high-
throughput dynamic analysis of single cells while simultaneously monitoring the dynamics of the 
intracellular environment which is of critical importance for many biochemical applications
65, 66, 
68, 69
 Droplet microfluidics coupled with increasingly sensitive molecular biology tools has 
opened up the venue for transformational progress in clinical diagnostics and prognostics in the 
past few years.
67, 70
 Several reports have demonstrated the application of droplet microfluidics 
for performing biological assays such as PCR based biomarker discovery
71
 enzyme kinetics 
analysis 
72
, cell-cell communication 
73
 and several other applications 
69
. Traditionally, the 
analysis of biochemical fluorescent substrates in single cells using droplet microfluidics was 
performed using a two-step process. First, a device was used to encapsulate individual cells in 
droplets followed by off-chip collection and incubation. These droplets were then transferred to a 
second device for screening and analysis. 
74
 Recent efforts with droplet generators have 
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incorporated a droplet trapping array downstream of the flow channel to facilitate dynamic high-
throughput screening of single cells on-chip while minimizing the chance for contamination and 
decreasing operator influence.
75
 Interesting recent examples include a microfluidic trap array 
developed by Jackson-Holmes and colleagues for analyzing individual stem cell aggregates
76
 and 




In this work, a microfluidic droplet trapping array was fabricated to perform single cell 
analysis of CPP uptake in intact HeLa cells. The microfluidic platform consists of a 787-member 
overhead droplet trapping array downstream of a flow focusing droplet generation junction. 
Single cell uptake and population-based trends were observed for four different CPPs: two 
commercially available peptides (TAT and ARG) and two novel CPPs previously developed by 
Safa et al.
61
 Single cancer cells were encapsulated in droplets and sorted in the trapping array for 
fluorescent imaging. Images were processed by identifying regions of interest (ROIs) around 
individual cells to quantify the uptake signals measured by fluorescent microscopy. The 
measured signals were analyzed by R programming to perform hierarchical cluster analysis and 
bin the cells into underlying subpopulations based on peptide uptake. This analysis confirmed 
previous findings that CPP uptake is strongly dependent upon concentration.  The intracellular 
heterogeneity of peptide uptake in single cells was also characterized to reveal a correlation with 
the overall uptake efficiency. Results indicated that increasing peptide concentrations caused the 
CPPs to distribute more homogeneously in the cytoplasm of the cells and resulted a stronger 
uptake signal. Numerical simulations on single cell scatter plots and population histograms 
allowed for predictive analysis of cell populations and identification of common trends. Finally, 




) and OPM-2 (average cross-sectional area of 90 µm
2
) identified that although fluorescent 
intensities obtained for the same peptide were significantly different in the two cell lines, 
fluorescent densities obtained by normalizing the intracellular fluorescent signals to cell size 
were within a small range demonstrating the effect of cell size on the fluorescent signals. 
4.2 Materials and Methods 
4.2.1 Device Design 
The features of the microfluidic droplet trapping array consist of two layers, each of 
which has a height of 40 μm. The bottom layer consists of the flow focusing junction followed 
by a large open channel. The features of the flow focusing junction and oil and water inlets in the 
bottom layer are similar to those presented by Mazutis et al.
22
 The top layer consists of the 
trapping array which is located overhead of the larger channel, downstream of the flow focusing 
junction (Figure 4.1). The oil and water phase inlet ports are 750 and 470 μm in diameter. The oil 
inlet channel is split into two channel which converge at the flow focusing junction in channels 
that are 20 μm wide. 
 
 
Figure 4.1. Schematic of the microfluidic droplet trapping platform. (A) Top view of the 
device illustrating the (1) oil inlet, (2) water inlet, (3) flow-focusing junction, (4) droplet 
trapping array, and (5) outlet. (B) Schematic of the generation and trapping of droplets 
containing cells into 70 µm circular microwells imprinted 40 µm into the PDMS directly 
above the downstream channel.  (C) Overlaid microscope image of aqueous droplet containing 
5(6)-carboxyfluoroescein isolated in the trapping array. 
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 The aqueous inlet stream enters the junction in a channel that is 34 μm wide. After 
formation, droplets flow through a 700 μm narrow channel (to allow for droplet stabilization) 
and into the trapping array channel. Here, an array of 787 microwells, 70 μm in diameter and 40 
μm in height are imprinted into the overhead PDMS in a hexagonal pattern to facilitate optimal 
trapping and prevent droplet ejection. The trapping array is similar to one presented by Khorshidi 
et al.
75
 In order to assure high droplet trapping efficiency, vertical fins were incorporated in the 
bottom fluidic layer to increase the residence time of the droplets and prevent them from flowing 
adjacent to the walls and bypassing the trapping array. At the end of the trapping array channel, 
an outlet port was incorporated for the flow to exit the channel. 
4.2.2 Device Fabrication 
The droplet microfluidic trapping array was fabricated using a combination of soft 
lithography and polydimethylsiloxane (PDMS) replication techniques as previously 
reported.
22
 AutoCAD (2015 version, AutoDesk) was used to create geometries for the 
microchannels which were printed onto iron oxide/chrome masks (Front Range). A 
silicon master was fabricated using a two-step lithography process to generate the bottom 
fluidic layer and top trapping array. SU-8 2025 (MicroChem) was spun onto a clean 4” 
silicon wafer (University Wafer) using a spin coater (WS-650 Series Spin Processor, 
Laurell Technologies Corp) at 3000 rpm for 30 s to achieve a thickness of 40 μm for the 
bottom fluidic layer. The wafer was pre-baked at 65°C for 5 min and then baked at 95°C 
for 25 min followed by a gradual cooldown to 25 °C. UV exposure was performed in a 
custom-built UV exposure system with a Blak-Ray B-100 series UV lamp (UVP, LLC) 
with 1 mW/cm power intensity for 60 s. A post exposure bake was performed at 65°C for 
5 min and at 95°C for 25 min. A second 40 μm layer of SU-8 2025 was spun onto the 
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wafer to generate the overhead trapping array followed by the same pre-exposure bake, 
UV exposure, and post-exposure bake steps. Following the second post exposure bake 
step, the wafer was immersed in an SU-8 developer solution (MicroChem) for ~5 min 
followed by a rinse with isopropyl alcohol (VWR) to remove all un-crosslinked SU-8. 
The wafer was dried with compressed nitrogen and then hard baked at 150°C for 30 min 
to stabilize the patterns.  
PDMS replication was performed using traditional methods. Briefly, Sylgard 184 
(Dow Corning, Ellsworth Adhesives) was poured onto the silicon master at a ratio of 10:1 
(base:curing agent). The PDMS was cured on a hot plate at 65°C for a minimum of 6 
hours (but no longer than 24 hours). The inlet and outlet holes were created using a 
blunted 18-gauge needle (BD Biosciences). The PDMS replica was cut and permanently 
bonded to a glass coverslip (75mm x 25 mm, Corning) using a Harrick Plasma Cleaner 
PDC-32G (Harrick Plasma) for 30 s. Microfluidic devices were allowed a minimum 
waiting period of 3 h to yield optimal bonding between the PDMS and the glass. The 
fluidic channels were rendered hydrophobic by Aquapel treatment to prevent channel 
wetting and the formation of a continuous aqueous phase in the device. After treatment, 
the device was flushed with Novec 7500 (3M) carrier oil and dried by compressed 
nitrogen. Prior to experimentation, the device was placed in a vacuum chamber for 30 
min to prevent the diffusion of gas bubbles from the PDMS into the fluidic channels. 
Droplet generation and trapping was facilitated by pressure drive flow from two 
syringe pumps (Pico Plus Elite, Harvard Apparatus) connected to the microfluidic device 
using 0.022” polytetrafluoroethylene (PTFE) tubing (Cole Parmer). The PTFE tubing was 
connected to 1 cc syringes (BD Biosciences) with 23-gauge luek lok needles (BD 
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Biosciences) which were placed in the syringe pumps. The oil phase was injected into the 
device at a rate of 230 μL/h and contained Novec 7500 oil supplemented with 3 wt% 008-
Neat Fluorosurfactant (Ran Biotechnologies) to prevent droplet accumulation in the 
device. The aqueous phase was injected into the device at a rate of 90 μL/h and contained 
either deionized water, extracellular buffer (ECB; 5.036 mM HEPES pH 7.4, 136.89 mM 
NaCl, 2.68 mM KCl, 2.066 mM MgCl₂ •6H₂ O, 1.8 mM CaCl₂ •2H₂ O, and 5.55 mM 
glucose), or ECB with cells. Droplet generation and trapping was observed using an 
inverted fluorescent microscope (DMi8, Lecia Microsystems) with a digital CMOS 
camera C11440 (Hamamatsu Photonics) equipped with LASX software 3.3.0 to image 
and analyse droplets and cells. After the droplet trapping array was filled, the device was 
flushed with only the oil phase to remove any remaining droplets from the channel. 
4.2.3 Peptide Synthesis and Purification 
The RWRWR and OWRWR peptides were synthesized on a Tribute peptide synthesizer 
(Protein Technologies) utilizing a standard Fmoc peptide chemistry protocol on a 100 µmol scale 
using rink amide resin (189 mg, 0.53 mmol/g).  Five-fold excess of Fmoc-amino acids (Fmoc-
Arg(Pbf)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, Fmoc-Orn-OH, Fmoc-d-Pro-OH, Fmoc-Gly-
OH, Fmoc-Ile-OH, Fmoc-Gln(Trt)-OH, Fmoc-Orn(Aloc)-OH) and HCTU, in the presence of 10 
equivalents of NMM were used for each of the amino acid coupling steps (10 min) with NMP as 
the solvent.  A solution of acetic anhydride, NMM and NMP (1:1:3) was added to the 
deprotected resin and shaken for 30 minutes to acetylate the N-terminus of the peptide.  Once the 
peptide synthesis was complete, the resin was washed with DMF (3x30 sec) then DCM (3x30 
sec).  The Aloc group was removed with three-fold excess of palladium in 4 ml of CHCl3-
HOAc-NMM (37:2:1) under nitrogen for 2 hrs.  The resin was then washed with DCM (3x30 
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sec) followed by DMF (3x30 sec).  In the dark, FAM (5,6-carboxyfluorescien Chem Impex 
International) was coupled to the delta nitrogen of the ornithine side chain with four-fold excess 
of FAM, HOBt, PyBOP and DIEA in 3mL DMF for 24 h and then repeated for 8 h.  The peptide 
resin was washed with DMF (3x30 sec) and DCM (3x30 sec). The peptide was cleaved from the 
resin and side-chain deprotected using TFA/water/TIPS (4 mL, 95:2.5:2.5) for 3 hours and 
collected in a 50-mL centrifuge tube.  The cleavage reaction was repeated for 10 minutes. The 
cleavage solutions for the peptide were combined and concentrated in vacuo.  Cold diethyl ether 
was then added to the peptide solution to precipitate the crude peptide.  The peptide was 
centrifuged for 10 minutes (4,000 rpm) and the ether layer decanted.  Fresh cold diethyl ether 
was added, and the pelleted peptide was resuspended.  The peptide was centrifuged again, and 
the procedure was repeated 5 times in total.  After the final ether wash, the peptide pellet was 
dissolved in 5 mL water containing 0.1% TFA, frozen and lyophilized.   
HPLC analysis was performed with a Waters 616 pump, Waters 2707 Autosampler, and 
996 Photodiode Assay Detector which are controlled by Waters Empower 2 software. The 
separation was performed on an Agilent Zorbax 300 SB-C18 (5 um, 4.6 x 250 mm) with an 
Agilent guard column Zorbax 300 SB-C18 (5 um, 4.6 x 12.5 mm).  Elution was done with a 
linear 5% to 55% gradient of solvent B (0.1% TFA in acetonitrile) into A (0.1% TFA in water) 
over 50 min at a 1 mL/min flow rate with UV detection at 442 nm.  Preparative HPLC runs were 
performed with a Waters prep LC Controller, Waters Sample Injector, and 2489 UV/Visible 
Detector which are controlled by Waters Empower 2 software. The separation was performed on 
a Agilent Zorbax 300SB-C18 PrepHT column (7 um, 21.2× 250 mm) with Zorbax 300SB-C18 
PrepHT guard column (7 um 21.2 × 10 mm) using a linear 5% to 55% gradient of solvent B 
(0.1% TFA in acetonitrile) into A (0.1% TFA in water) over 50 min at a 20 mL/min flow rate 
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with UV detection at 215 nm.  Fractions of high (>95%) HPLC purity of each peptide and with 
the expected mass were combined and lyophilized.  
4.2.4 Cell Culture and Reagents 
 
HeLa cells (LSU AgCenter Tissue Culture Facility) and green fluorescent protein (GFP)-
expressing HeLa cells (GFP-HeLa) were maintained in Dulbecco’s modified eagle medium 
(DMEM) with 10% v/v fetal bovine serum (FBS, Seradigm). OPM2 cells were maintained in 
RPMI 1640 media supplemented with 12% FBS, 21.8 mM glucose, 8.6 mM HEPES (pH 7.4) 
and 1.0 mM sodium pyruvate. All media components were from Corning unless otherwise noted. 
FAM-tagged TAT and FAM-tagged ARG peptides were purchased from Anaspec. 
4.2.5 Cell permeability Assay 
The quantification of peptide uptake was performed using an adapted protocol from Qian 
et al
39
. All peptides were reconstituted in sodium phosphate buffer (2.26 mM NaH2PO4•H2O and 
8.43 mM Na2HPO4•7H2O, pH 7.4). Stock peptide concentration was determined using a 
NanoDrop (Thermo Scientific) at the wavelength of 492 nm using the UV-Vis function and 
diluted in ECB to reach the desired concentration. For experiments with HeLa cells, the cells 
were washed with phosphate buffered saline (PBS: 137 mM NaCl, 10 mM Na2HPO4, 27 mM 
KCl, and 1.75 mM KH2PO4 at pH 7.4), trypsinized, and re-suspended in ECB to a final density 
of 6x10
6
 cells/mL. The cells were washed an additional time with ECB and then re-suspended in 
2 mL of the peptide solutions. OPM2 cells were pelleted (1800 rcf, 2.5 min at 25°C), washed 
twice with ECB, and re-suspended to final density of 6x10
6
 cells/mL. These cells were then 
pelleted and re-suspended in 2 mL of the peptide solutions. Cells were incubated with the 
peptides for 60 min at 37°C in the dark. After incubation, the cell suspension was centrifuged 
(1800 rcf, 2.5 min at 25°C) to remove the peptide solution followed by two additional washes 
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with ECB. Finally, the cells were re-suspended in 2 mL ECB, placed into a 5 ml syringe (BD 
Biosciences) and immediately injected into the aqueous inlet of the microfluidic device. 
Experiments with GFP-HeLa cells followed a similar protocol except for the peptide incubation 
step. 
4.2.6 Image Processing and Statistical Analysis 
 
The DMi8 inverted fluorescent microscope was used to collect images of trapped droplets 
across the entire trapping array using the FITC filter set (λex: 440-520 nm and λem = 497-557 nm) 
from Chroma Tech. The fluorescent intensities of individual cells were quantified in gray values 
using thresholding in the LAS X software by defining ROIs around each individual cell. Random 
ROIs were also defined in free space away from the trapped droplets to measure the droplet 
background noise for each image. It was confirmed that the background noise measured using 
the FITC filter set fit within a very small range for all images. The noise was found to be slightly 
different across different experiments depending on the peptide studied. Peptides with higher 
solubilities demonstrated a lower median droplet background noise. The fluorescent value for 
each individual cell was normalized against the noise measured for the same image by 
subtracting the noise from the signal. A minimum of 100 HeLa cells were analyzed per 
experiment.  
The normalized fluorescent signals for each population of single cells were clustered in 
subpopulations using average linkage hierarchical cluster analysis by R programming. As an 
illustration of the analysis method, the clustering dendrogram obtained for HeLa cells incubated 
with a 10 µM OWRWR peptide solution is illustrated in Figure 3A. In this dendrogram, the 
horizontal axis represents the datapoints obtained for individual cells, and the vertical axis 
represents dissimilarity. The dissimilarity was calculated using Euclidean distance 
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measure. Finally, the dendrogram was cut at an appropriate dissimilarity threshold to 
produce the clusters. The optimal number of clusters for binning each dataset were 
determined exclusively for that dataset. An established R function named NbClust as 
reported by Charrad, et. al was used to determine the optimal number of clusters
77
. This 
function calculated 30 defined deterministic indices by varying the number of clusters to 
report the optimal cluster number by maximizing the number of favorable indices. 
Another established R function, named clValid as reported by Brock, et. al.  was then 
used to assess the quality of clustering using three indices. Each index in this function 
reflected the compactness, connectedness, and separation of the cluster partitions
78
. This 
produced the clusters presented in Figure 4.3B. These clusters were then marked on the 
data histogram (Figure 4.3C). Population histograms, simulation functions, and statistical 
analysis presented in Figure 4.5 and Figures 4.6-4.9 were performed using the statistical 
analysis package in Origin Pro. 
4.3 Results and Discussion 
 
4.3.1 Single Cell Fluorescent Imaging of CPP Uptake in Intact Cells Using a Microfluidic 
Droplet Trapping Array. 
 
The droplet microfluidic trapping allowed for the rapid and facile encapsulation of single 
cells incubated with four different CPPs to directly quantify peptide uptake using fluorescent 
microscopy. The microfluidic device was confirmed to generate aqueous droplets at a rate of 200 
Hz coupled with a ~99% droplet trapping efficiency in the trapping array. The device was 
capable of single cell encapsulation in ~40-60% of the traps. Submerging the device in water 
allowed for maintaining droplet stability for at least 14 hours. Live/dead staining with Calcein 
AM and Ethidium homodimer verified cell viability on-chip for at least 5 hours which was 
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beyond the experimental time range used in this work (data not shown). By injecting CPP-treated 
cells into the aqueous inlet of the device, single cells were isolated in aqueous droplets and 
collected in the overhead trapping array.  The update efficiencies of four different CPPs were 
studied here: TAT [FAM-YGRKKRRQRRR], ARG [FAM-RRRRRRRRR], RWRWR [Ac-
RWVRVpGO(FAM)WIRQ-NH2], and OWRWR [Ac-OWVRVpGO(FAM)WIRQ-NH2].  TAT 
and ARG are commercially-available, well-studied CPPs. RWRWR and OWRWR are novel 
peptides previously described by Safa et al that show enhanced stability under intracellular 
conditions; however, these peptides were found to exhibit lower uptake efficiencies when using 
bulk measurements like fluorometry.
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 Select bright-field and FITC images of CPP uptake in 
single intact cells are illustrated in Figure 4.2. 
 The microfluidic device was used to quantify peptide uptake for the four peptides at two 
different concentration (10 µM and 50 µM) (Figure 4.2). Peptide- and concentration-dependent 
studies were performed to examine the effect of peptide sequence and peptide initial 
concentration on CPP uptake efficiency at the single cell level and provide an in-depth analysis 
of each sample across a population. Two different cell lines were used to examine the effect of 
cell size and cell type on peptide uptake. HeLa cells are a larger, adherent cervical cancer cell 
line and OPM2 are a smaller, non-adherent multiple myeloma-derived cell line. The microfluidic 
platform was able to encapsulate both HeLa cells (Figure 4.2A-B) and OPM2 cells (Figure 4.2C) 
incubated with the RWRWR peptide (Figure 4.2A), TAT peptide (Figure 4.2B), and the ARG 
peptide (Figure 4.2C). These images are representative of all experiments for the four peptides at 
the two concentrations with the two different cell lines.  
67 
The images collected of CPP uptake into the cells in the microfluidic device are similar in 






Figure 4.2. Visualization of CPP uptake in single intact HeLa cells encapsulated in droplets. 
Brightfield (left) and fluorescent (right) images of (A) HeLa cells incubated with a 50 µM 
RWRWR peptide solution and (B) HeLa cells incubated with a 50 µM TAT peptide solution 
at two magnifications (C) OPM2 cells incubated with a 50 µM ARG peptide solution. Scale 
bar is 70 µm in all images. 
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4.3.2 Quantification of CPP Uptake in Intact Single Cells Demonstrates Population 
Heterogeneity. 
The fluorescent signals produced due to CPP uptake in individual cells were quantified, 
normalized, and used to identify subpopulations of cells based on the degree of peptide uptake. 
The following analysis is for the uptake of 10 µM OWRWR in HeLa cells (Figure 4.3); however, 
the approach and results were similar in nature for the other three peptides at both 
concentrations. For this experiment, the optimal number of clusters was identified to be four by 




To assess the goodness of the clustering in terms of compactness, connectedness, and 




 and Silhouette 
Width
81
) were calculated using the clValid function.
78
 Connectivity is a number in the range 
between [0,∞), to be minimized, the Dunn index is a number in the range between [0,∞), to be 
maximized, and Silhouette is a number in a range between [-1, 1] to be maximized. The 
calculated values for these indices for all the experiments are reported in Table 4.1. For the cells 
incubated with 10 µM OWRWR, these values were found to be 12.02 for Connectivity, 0.01 for 
Dunn, and 0.65 for Silhouette. The relatively low connectivity value coupled with the relatively 
high Silhouette value suggest adequate clustering results corresponding to population 
heterogeneity. Interestingly, the Dunn index as defined to be the ratio of the smallest distance 
between observations not in the same cluster to the largest intra-cluster distance was found to be 
0.01. The small value calculated for the Dunn index suggested that the subpopulations identified 
are not completely distinct or well-separated. 
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This result is not unexpected given that all the subpopulations identified belong to a 




Figure 4.3. Identification of distinct subpopulations of HeLa cells based on peptide uptake 
using linkage hierarchical cluster analysis. A population of HeLa cells were incubated with a 
10 µM solution of OWRWR and imaged using the microfluidic droplet trapping array. (A) 
Agglomerative dendrogram tree for hierarchical cluster analysis. The horizontal axis 
represents the fluorescent signal from each individual cell analyzed and the vertical axis 
represents dissimilarity measured using the Euclidean distance measure. (B) The cells were 
binned into four clusters as the subpopulations present in the sample. (C) Distribution 
histogram of data for n= 537 cells demonstrating a logarithmic normal trend and the four 
identified subpopulations.  
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The subtle difference observed among the subpopulations can only be attributed to cell to 
cell heterogeneity.  This analysis was repeated for each experimental condition (peptide and 




In all cases, peptide uptake in HeLa cells was found to be heterogenous with the 
distribution of the normalized fluorescent signals following a logarithmic trend with r-squared 
values above 0.95 (Figure 4.3C). Similarly, a study by Wang et. al.
65
 had previously reported a 
logarithmic normal population distribution of TAT-quantum dot endocytosis in Chinese hamster 
ovary (CHO) cells. The identification of such behavioral patterns in biological events through 
single cell analysis can provide important insight to predict cell behavior as triggered by certain 
environmental stimuli 
4.3.3 Clustering of Cells into Distinct Subpopulations Based on Peptide Uptake Identifies a 
Potential Bias in Comparing Population Means to Overall Peptide Uptake 
 To visualize the distribution and size of each of the subpopulations, the clusters were 
grouped using a bubble plot (Figure 4.4). As expected, the findings confirm an approximate 10-
fold increase in the normalized signals when increasing the peptide concentration from 10 µM to 
 
Connectivity Dunn Silhouette 
10 𝛍𝐌 RWRWR 5.49 0.06 0.67 
50 𝛍𝐌 RWRWR 12.52 0.04 0.70 
10 𝛍𝐌 OWRWR 12.02 0.01 0.65 
50 𝛍𝐌 OWRWR 11.78 0.02 0.68 
10 𝛍𝐌 TAT 7.28 0.05 0.61 
50 𝛍𝐌 TAT 16.39 0.03 0.61 
10 𝛍𝐌 ARG 8.62 0.03 0.66 
50 𝛍𝐌 ARG 13.76 0.10 0.68 
 
Table 4.1. Deterministic indices testing the goodness of hierarchical clustering Connectivity 
index, Dunn index, and Silhouette width values for assessing the goodness of the clustering 
in terms of compactness, connectedness, and separation of the cluster partitions. 
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50 µM. This is consistent with previous data presented by Safa, et. al
61
 using off-chip, bulk 
fluorescent studies.
61
 Furthermore, this analysis found that the largest cluster for all four peptides 
at both concentrations was the cluster representing the lowest grouping of normalized fluorescent 
signals. This implies that there is a significant portion of the cellular population with a lower 
degree of peptide uptake, which can have dramatic results if the CPPs are conjugated to 
biosensors or therapeutics. Conversely, each peptide at each concentration was observed to have 
a small population of cells with extremely high normalized fluorescent signals which correspond 
to substantial uptake of the peptides. The presence of these high performers has the potential to 
bias results when using bulk population metrics like fluorometry or only looking at 3-5 cells with 
fluorescent microscopy, the two most common approaches utilized to assess CPP uptake. For 
example, the ARG peptide is widely accepted to be an ideal CPP; however, the finding here 
implies that the global uptake of ARG across a net population is biased by a small subpopulation 
with very high uptake. This can be observed when comparing the population mean and median 
values to the values for each of the subpopulations incubated with 50 µM peptide (Figure 4.4B). 
The mean value for 50 µM ARG is 12462 compared to values of 4963 for 50 µM OWRWR, 
4877 for 50 µM RWRWR, and 2617 for 50 µM TAT (Figure 4.4B). Using the population mean 
alone would imply that the ARG peptide yields the best uptake for all cells; however, the lowest 
cluster for ARG is comparable in size and normalized fluorescent as those for OWRWR and 
TAT suggesting that most of the population of cells will experience similar degrees of peptide 
uptake for all three peptides. 
This variation between population mean and population distribution was not as extreme 
when cells were incubated with 10 µM peptide solutions suggesting that the heterogeneous 
uptake of peptide is concentration dependent. In fact, the population distribution for cells 
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incubated with 10 µM RWRWR, TAT, and ARG all follow a similar trend of three 
subpopulations with the largest cluster having a normalized fluorescence of ~1200 (Figure 4.4A).  
 
 
Figure 4.4. Distribution and quantification of distinct subpopulation of cells based on CPP 
uptake.) (A) The normalized fluorescence signals of intact HeLa cells incubated with 10 µM 
peptide solutions quantified by fluorescent microscopy and clustered into 3-4 subpopulations. 
The number inside each bubble corresponds to the relative size of the cluster for each 
subpopulation. The mean (red ‘X’) and median (red vertical line) of the entire population is 
shown for comparison. (B) A similar quantification and clustering as shown in (A) but for 
HeLa cells incubated with 50 µM peptide solution.  
 
73 
Interestingly, a similar distribution of intracellular fluorescence was observed for HeLa 
cells that were stably transfected with green fluorescent protein, GFP-HeLa (Figure 4.4B). This 
confirms prior findings about transfection efficiencies and how some cells exhibit a high degree 
of transfection while others experience a lesser degree of transfection depending on cell cycle 
among other factors.
82
 These results also suggest that CPP uptake may follow a similar trend as 
cellular transfection with small subpopulations exhibiting very high transfection efficiencies. 
4.3.4 Overall CPP Uptake Efficiency Correlates to Intracellular Peptide Distribution in a 
Concentration-Dependent Manner. 
Based on the strong dependence of peptide concentration on population heterogeneity, an 
additional analysis was performed to examine how peptide concentration effected the 
intracellular peptide distribution in cells. To accomplish this, the coefficient of variance (COV) 
of intracellular fluorescence was measured for each individual cell analyzed. Here, the COV was 
defined as the standard deviation of the intracellular fluorescent signals measured for the pixels 
within the ROI defined around the cell by their mean value. As a result, the COV is a 
dimensionless metric for the intracellular heterogeneity of peptide distribution or the 
punctateness level of the peptide taken up by the cell. A poor intracellular distribution is often 
associated with peptide isolation in membrane-bound vesicles which limits the CPPs ability to 
uniformly deliver a cargo to a cell.
83
 A comparison between intracellular heterogeneity (COV) 
and mean fluorescent signals was performed for individual cells (Figure 4.5A) and for median 
values of intracellular heterogeneity and fluorescent intensity of the entire population (Figure 
4.5B). It was observed that cells treated with 10 µM peptide solutions clustered within a small 
range in areas with lower intensities and higher intracellular heterogeneities (Figure 4.5A, upper 
left), although this occurred to variant extents for different peptides. By increasing the 
concentration of each peptide, fluorescence intensities expanded within a wider range to areas 
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with higher intensities and lower intracellular heterogeneities (Figure 4.5A, bottom right). When 
comparing the median population values of intracellular heterogeneity and fluorescent intensity 
(Figure 4.5B), three groupings could be identified by where the median values appeared on the 
plot. The upper left quadrant, which contains median values for 10 µM OWRWR, 10 µM 
RWRWR, and 10 µM TAT, is representative of highly punctate intracellular distribution of 
peptides coupled with a relatively low values for overall peptide uptake. This implies that these 
three peptides at these incubation concentrations will have a lower degree of internalization and a 
poorer intracellular distribution. The lower right quadrant is representative of cells with a lower 
level of intracellular heterogeneity (or punctateness) coupled with a high or very high overall 
peptide uptake efficiency. These three conditions inclue cells incubated with 50 µM peptide 
solutions of TAT, RWRWR, and OWRWR. This implies that increasing peptide concentration 
results in lower intracellular heterogeneity which correlates to higher intracellular homogeneity 
and higher overall peptide uptake efficiency. Intriguingly, the one exception to this finding was 
the TAT peptide which found that increasing the concentration decreased the intracellular 
heterogeneity yet did not significantly increase the overall uptake efficiency. This may be 
attributed to the high cytotoxicity of this peptide at high concnetrations.
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 Intracellular peptide 
distribution is an important characteristic of peptide-cell interaction that is often used to develop 
hypotheses and make conclusions about peptide uptake mechanism.
51, 52
 This important 
parameter is usually investigated through live cell microscopy and described qualitatively based 
on analyzing a small number of cells versus being quantified for a large number of cells.
52
 
A scatter plot illustrating the correlation between intracellular peptide heterogeneity and 
fluorescence intensity of 500 individual cells incubated with 10 µM OWRWR is shown in Figure 
4.5C. The correlation was numerically simulated with an exponential decay regression which 
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successfully predicted the cell population behavior and converged with p<0.00001. This further 
characterizes the trends observed in Figure 4.5A confirming that the majority of cells clustered in 
regions with lower intensities and higher intracellular heterogeneity which correlates with the 
data presented in Figure 4.4. To quantify this accumulation, a population histogram was created 
to illustrate a logarithmic normal distribution (Figure 4.5D).  
 
 
Figure 4.5. The concentration-dependent correlation between intracellular peptide 
distribution and CPP uptake efficiency. A coefficient of variance (COV) was calculated for 
each individual cell analyzed as a metric of intracellular heterogeneity to determine the effect 
of peptide concentration on intracellular distribution. (A) Intracellular heterogeneity (COV) 
was compared to the mean intracellular fluorescent signal for single HeLa cells incubated 
with the four peptides at the two concentrations. (B) Comparison of the median values of the 
intracellular heterogeneity (COV) and the median cellular fluorescence intensity for the entire 
population of HeLa cells analyzed. The legends are the same in A and B. (C) A correlation 
between intracellular heterogeneity (COV) and fluorescent intensity for cells incubated with 
10 µM OWRWR simulated with an exponential decay function (n=537, p<0.0001). (D) 
Population distribution of fluorescent intensity signals for HeLa cells incubated with 10 µM 
OWRWR numerically simulated with the Kernel density function (p<0.0001). 
 
76 
This histogram was simulated with a Kernel density function that successfully fits the 
trend to predict the population distribution. Population distributions of fluorescent intensity 
versus intracellular heterogeneity for all peptides and concentrations studied are provided in 
Figures 4.6-4.9 with all histograms demonstrating logarithmic normal distributions. 
 
 
 Comparing the histograms for the two concentrations of each peptide showed that 
increasing the incubation concentration shifts the peak of the intracellular heterogeneity 
histogram to lower values. The population histogram for the GFP-expressing HeLa cells (Figure 
4.10) follows the same logarithmic trend as CPP treated cells. The results illustrated in Figure 4.5 
and Figures 4.6-4.9 demonstrate that increasing peptide incubation concentration shifts the 
Figure 4.6. Population distribution of OWRWR peptide internalization and intracellular 
heterogeneity Uptake of (A) 10 µM (n=539) and (B) 50 µM OWRWR peptide solution in 
HeLa cells (n=274). (C) Observed intracellular heterogeneity (COV) of (C) 10 µM and (D) 50 
µM OWRWR peptide solution in HeLa cells. All distributions demonstrate a logarithmic 
normal trend as mathematically simulated by Kernel density function (p<0.05) 
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histogram of cells towards lower intracellular heterogeneities and in all cases (with the exception 
of TAT) results in a significantly higher uptake efficiency.  
 
 
This identifies a strong direct correlation between the intracellular peptide homogeneity 
and overall uptake efficiency for those peptides as illustrated for the 10 µM OWRWR (Figure 
4.5C). Similar trends were previously described qualitatively in off-chip efforts characterizing 
CPP uptake and internalization mechanisms.
52
  
Additionally, a single cell study  performed by Cao et al.
85
 recently identified a direct 
quantitative correlation between fluorescence intensity of cells and the cytosolic/nuclear 
localization of native proteins. 
Figure 4.7. Population distributions of RWRWR peptide internalization and intracellular 
heterogeneity. Uptake of (A) 10 µM (n=177) and (B) 50 µM RWRWR peptide solution in 
HeLa cells (n=178). (C) Observed intracellular heterogeneity (COV) of (C) 10 µM and (D) 50 
µM RWRWR peptide solution in HeLa cells. All distributions demonstrate a logarithmic 






Figure 4.8. Population distributions of TAT peptide internalization and intracellular 
heterogeneity Uptake of (A) 10 µM (n=98) and (B) 50 µM TAT peptide solution in HeLa 
cells (n=180). (C) Observed intracellular heterogeneity (COV) of (C) 10 µM and (D) 50 µM 
TAT peptide solution in HeLa cells. All distributions demonstrate a logarithmic normal trend 
as mathematically simulated by Kernel density function (p<0.05) 
 
Figure 4.9. Population distributions of ARG peptide internalization and intracellular 
heterogeneity Uptake of (A) 10 µM (n=129) and (B) 50 µM ARG peptide solution in HeLa 
cells (n=95). (C) Observed intracellular heterogeneity (COV) of (C) 10 µM and (D) 50 µM 
ARG peptide solution in HeLa cells. All distributions demonstrate a logarithmic normal trend 





4.3.5 Cell Size Does Not Affect Peptide Uptake Efficiency But Does Affect The Net Amount 
of Internalized Peptide. 
The microfluidic platform was finally used to identify the relationship between peptide 
uptake and cell size. Current bulk approaches like fluorometry oftentimes use fluorescent 
intensity as a metric of peptide uptake; however, this value can be biased when comparing 
uptake efficiencies between two different types of cells, especially those that differ in size. To 
explore this, peptide uptake was studies in the OPM2 cell line. OPM2 cells are a suspension, 
myeloma-derived cell line with an average measured cross-sectional area of 90 µm
2
 compared to 
HeLa cells which exhibit an average measured cross-sectional area of 500 µm
2
. Both cell lines 
were incubated with 50 µM ARG solutions and single cell analysis of intracellular fluorescent 
signal was performed (Figure 4.11). As expected, the mean fluorescent signal was significantly 
lower for OPM2 cells compared to HeLa cells under similar experimental conditions 
(p<0.00001). Since HeLa and OPM2 cells are significantly different in size, it was hypothesized 
Figure 4.10. Population distribution of intracellular fluorescence in GFP-expressing HeLa 
cells. The distribution histogram demonstrates a logarithmic normal trend as mathematically 
simulated by Kernel density function (n=105, p<0.05) 
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that the observed difference was due to the smaller size of the OPM-2 cells. To account for size, 
the mean fluorescent density was calculated which divided the median fluorescent signal by the 
average cross-sectional area for the population of cells. This new metric, which removed the bias 
of cell size, confirmed this hypothesis and illustrated that unlike overall fluorescent output, the 
fluorescent density was comparable between the two cells lines exposed to the same peptide at 




In this paper, a microfluidic droplet generator and overhead trapping array was used to 
perform high-throughput single cell analysis on the concentration dependent uptake of four 
different cell penetrating peptides. Cells treated with 10 µM and 50 µM peptide solutions were 
Figure 4.11 Effect of cell line on peptide uptake efficiency. HeLa cells (average cross-
sectional area of 500 µm
2
) and OPM-2 cells (average cross-sectional area 90 µm
2
) were 
incubated with 50 µM ARG or 60 minutes at 37 °C. (A) The mean fluorescence intensity for 
the entire population of cells was compared for HeLa (n=97 cells) and OPM2 (n=26 cells). ‘*’ 
denotes p<0.00001 (B) The mean fluorescent intensity values for the entire population of cells 
was divided by the average cellular cross-sectional area for both HeLa and OPM2 cells to 
calculate the fluorescence density. ‘**’ denotes p>0.05  
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analyzed in terms of peptide uptake efficiency, intracellular distribution, and the correlation 
between them. Hierarchical cluster analysis was performed to identify the underlying 
subpopulations present in each dataset in terms of the fluorescent signal ranges the cells tend to 
cluster around in each case, and the percentage of cells falling into each subpopulation. 
Distribution histograms were obtained for the cells in terms of uptake efficiency and intracellular 
heterogeneity. Single cell results of these studies identified that increasing the initial peptide 
concentration results in a more homogeneous intracellular peptide distribution and a stronger 
uptake efficiency. All histograms followed a logarithmic normal trend. Kernel density functions 
numerically simulated the distribution histograms predicted cell behavior in terms of uptake 
efficiency and intracellular heterogeneity. The correlation between peptide concentration and 
intracellular heterogeneity was illustrated in a scatter plot for a model experiment (10 µM 
OWRWR) and numerically simulated using an exponential decay function to predict the 
behavior. Finally, repeating a select experiment (50 µM ARG) with a suspension cell line (OPM-
2) identified a significant difference in fluorescent signals, but normalizing the results by cell 
area resulted in similar fluorescent densities which revealed that the difference observed could 
mainly be attributed the smaller size of the OPM-2 cells. This works demonstrates the 
application of a microfluidic droplet trapping array for quantifying fluorescent cell permeable 
peptides in single intact cells and presents a statistical approach for performing single cell 
analysis of the samples. The microfluidic device and analytical approach can be further utilized 
to quantify enzyme activity using intracellular fluorescence tied to fluorescent based reporters to 
shed light on population heterogeneity associated with clinical samples. The technology has 
direct application in drug development and point of care personalized medicine. 
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Chapter 5: Direct Quantification of DUB Activity in Intact Cells Using a 
Protease-Resistant, Cell Permeable, Peptide-Based Reporter 
 
5.1 Introduction 
The ubiquitin-proteasome system (UPS) is the biochemical pathway in the cells primarily 
responsible for identifying misfolded and dysregulated proteins and targeting them to the 
proteasome for degradation
86
. The process starts with a cascade of three enzymes: E1 ubiquitin 
activating enzymes, E2 ubiquitin conjugating enzymes, and E3 ubiquitin ligases responsible for 
attaching a polyubiquitin chain to a lysine residue on a target protein. Ubiquitination directs a 
target protein to the 26S proteasome for degradation. Polyubiquitination is a reversible process 
mediated by a class of enzymes called deubiquitinating enzymes (DUBs). DUBs cleave the 
isopeptide bond formed between the C-terminal carboxylic acid of ubiquitin and the amine group 
on the side chain of lysine or ornithine to detach the polyubiquitin chain and rescue of the 
proteins from proteasomal degradation
86
.  
Recent research has established the importance of DUBs in several human pathologies 
including multiple myeloma (MM)
87
, neurodegenerative diseases 
88
, and cardiac diseases 
89
. 
Regulation of protein degradation makes members of the UPS, including the proteasome and 
DUBs, attractive pharmacological targets with significant efforts underway to identify new drugs 
such as small molecule inhibitors to regulate their activity.
7
 This is based on the clinical success 
of the proteasome inhibitor Bortezomib (Velcade) in the treatment of multiple myeloma, a cancer 
characterized by malignant plasma cells in the bone marrow that leads to a decreased immune 
response, weakening of the bones, kidney failure, and congestive heart failure. 
87
. The increased 
proteolytic activity of the proteasome is associated with a malignant transformation in multiple 
myeloma which results in Bortezomib-induced apoptosis in myeloma-derived cells by inhibiting 
the proteasome
1
. Due to the increased level of misfolded proteins in MM cells compared to non-
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tumor cells, they are significantly more dependent on such clearance mechanism than healthy 
cells. Next generation proteasome inhibitors Carfilzomib, Ixazomib, and Marizomib have also 
shown promising responses in clinical trials
2, 87
. A significant challenge with proteasome-
targeted therapeutics is the heterogeneity associated with cancer cells resulting in some patients 
initially being resistant to drugs while other patients develop a resistance to the proteasome 
inhibitors leading to relapse and death
87
. As such, tremendous attention has been devoted to 
discovering strategies to overcome this drug resistance. Interestingly, recent research has 
established the role of DUBs in developing a resistance to Bortezomib in MM patients with 
combinational treatment of DUB inhibitors and proteasome inhibitors leading to enhanced 
Bortezomib efficacy
6, 90-92
. This finding coupled with the cost of molecularly-targeted 
therapeutics, and the potential for severe side effects like peripheral neuropathy has created 
crucial needs for more advanced biochemical screening methods for personalized diagnosis 
towards the UPSs
5
. An ideal biochemical assay would be able to analyze DUB activity in clinical 
and pre-clinical samples during the early phases of drug discovery in addition to personalized 
diagnostics in the clinic.  
The current gold standard for measuring DUB activity consists of a full length ubiquitin 
(Ub) molecule with a fluorophore conjugated to the C-terminus (e.g, 7-amino-4-




 The underlying principle for this reporter is 
that as long as the fluorophore is bound to the substrate protein (Ub), no fluorescence will be 
observed in the sample. DUB-mediated cleavage of the reporter will free the C-terminal 
fluorophore and result in an easily detectable fluorescent signal that can be measured using 
methods like fluorometry. However, this reporter is limited to enzyme-only and lysate-based 
experiments which are not compatible with intact single cells. The result is that the end-point, 
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bulk measurments are incapable of accoutning for the significant heterogeneity associated with 
cancer cells which results in the inability to identify distinct subpopultions such as low 
occurrence, drug resistant cells. While recent work has improved this reporter by incorporating 
more sensitive fluorophores, 
10, 11
, different analytical outputs
11, 12
, or FRET- (Förster resonance 
energy transfer)-based pairings, 
13
 they are still limited to bulk measurements.  
Due to the high degree of heterogeneity associated with cancer cells, bulk measurements 
are often misleading
63
. Measuring the blended average responses of a population of cells 
provides no information regarding the distribution of single cell data, the range of the responses, 
or the population behavior. Population heterogeneity usually manifests itself in a variety of non-
normal distributions such as logarithmic or bimodal for which the mean value would be a very 
poor representative of the entire population and fails to identify the subpopulations present in the 
datasets
63
. Such subtle variations within the samples often can promote significant biological 
consequences given the high rate of cancer cell proliferation among other stimulants. Therefore, 
there is significant interest in developing high-throughput single cell analysis methods to shed 
light on population behavior by analyzing a large number of single intact cells.  Numerically 
simulated population behavior can provide new insight into describing tumor samples which can 
predict the patient response with greater accuracy when compared to traditional clinical methods 
that rely on bulk measurements and large databases for making crucial decisions about the course 
of treatment in cancer patients. Recent advancements in high-throughput lab-on-a-chip 
technologies coupled with fluorescent reporters that are example of such platforms that have 
revolutionized the state of single cell analysis
22, 67
.  
The goal of this work is to develop a long-lived, cell permeable, peptide-based reporter of 
DUB activity that is fluorescent, sensitive, and enzyme specific. Such a reporter would be ideally 
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suited to integrate into high-throughput single cell analysis techniques such as droplet 
microfluidics. To accomplish this, a long-lived, cell permeable β-hairpin sequence motif 
(Chapter 2)
61
 was conjugated to the four C-terminal amino acid residues from ubiquitin [LRGG].  
As an analytical output, the fluorophore AFC [7-Amino-4-trifluoromethylcoumarin] was 
conjugated to the C-terminal glycine residues that, when cleaved by the DUB, produces 
measurable fluorescent signal detected by fluorometry or microscopy. In this chapter, the 
synthesis of the reporter (termed Peptide 1) using solid phase peptide synthesis is described 
followed by a kinetic analysis in both HeLa and OPM-2 lysates. Regression analysis was 
performed to characterize the kinetic rate constants of the enzyme-substrate reactions which were 
compared to a commercially available DUB reporter [Peptide 3]. Experiments were repeated in 
presence and absence of the small molecule DUB inhibitor PR-619 at varying concentrations to 
confirm the specificity of the reporter to DUBs. In addition to characterizing reporter 
performance in lysates, kinetic studies were undertaken in intact HeLa cells. An alternate version 
of Peptide 1 (called Peptide 4) was synthesized to characterize peptide uptake in single intact 
cells, confirm cell viability, and visualize the peptide intracellular distribution. The 
concentration-dependent uptake kinetics and the distribution of cellular uptake were 
characterized and optimized to model the effectiveness of Peptide 1 in intact cells.  Reporter 
performance was characterized in intact cells using both fluorometry and fluorescent 
microscopy. An alternate version of the reporter (Peptide 2) that increased the length of the DUB 
substrate to 8 amino acids [LVLRLRGG] was also tested but was found to exhibit decreased 
kinetic performance. Finally, fluorescent microscopy was also performed in OPM-2 cells (a 
myeloma-derived cell line) to demonstrate the application of the reporter in multiple myeloma.  
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5.2 Materials and methods 
5.2.1 Chemicals 
Safety-catch resin (aliphatic), Fmoc-protected amino acids, 2-(6-Chloro-1H-
benzotriazole-1-yl)-1,1,3,3 - tetramethylaminium hexafluorophosphate (HCTU), trifluoroacetic 
acid (TFA) and rink amide SS resin were purchased from Advanced ChemTech (Louisville, 
KY).  Boc-Gly-AFC was purchased from AnaSpec (Fremont, CA).  (Ethyl 
cyano(hydroxyimino)acetato)-tri-(1-pyrrolidinyl)-phosphonium (PyBOP) was purchased from 
Novabiochem (Billerica, MA). Dimethylformamide (DMF) was purchased from Protein 
Technologies, Tucson, AZ.  Diisopropylethylamine (DIEA), triisopropylsilane, and N-
methylmorpholine (NMM) tetrakis(triphenylphosphine) palladium (0) (palladium), 5(6)-
carboxyfluorescein (FAM), chloroform (CHCl3), and methanol (MeOH) were purchased from 
Sigma Aldrich, St. Louis, MO.  Dichloromethane (DCM) and acetonitrile were purchased from 




-allyloxycarbonyl-L-ornithine (Fmoc-Orn(Aloc)-OH) was 
purchased from Chem-Impex International, Inc, Wood Dale, IL. 1-Hydroxy-6-
(trifluoromethyl)benzotriazole (HOBt) and (Ethyl cyano(hydroxyimino)acetato)-tri-(1-
pyrrolidinyl)-phosphonium (PyBOP) were purchased from Novabiochem, Billerica, MA. Glacial 
acetic acid was purchased from Alfa Aesar, Ward Hill, MA. Acetic anhydride was purchased 
from Fisher Scientific, Fair Lawn, NJ. All chemicals were used without further purification. 
5.2.2 Peptide Synthesis and Purification 
The synthesis of Peptide 1 [Ac-RWVRVpGO(FAM)WIRQ-LRGG-AFC] and Peptide 2 
[Ac-RWVRVpGO(FAM)WIRQ -LVLRLRGG-AFC] were based on the procedure outlined by 
Backes and Ellman (1999)
93
.  The first residue, Fmoc-Gly-OH, was manually coupled to the 
safety-catch resin in the following manner.  Safety-catch resin (637 mg, 0.7 mmol/g) was added 
87 
to a 50 mL syringe fitted with a teflon frit.  The resin was swollen by adding DMF (6 mL) and 
gently shaking for 30 minutes.  The resin was drained and then Fmoc-Gly-OH (528 mg, 4 eq.) 
and DIEA (464 µL, 6 eq) dissolved in 6 mL NMP was added and the resin slurry was shaken 
gently for 10 minutes.  PyBOP (900 mg, 3.9 eq) was added and the syringe was sealed and 
shaken overnight.  The resin was drained and the coupling procedure was repeated once more.  
The loading level was determined to be 0.26 mmol/g by the procedure outlined in Chan and 
White
94
.  With the preloaded Fmoc-Gly-safety-catch resin in hand, the remaining sequences of 
peptides 1 and 2 were synthesized on a Tribute peptide synthesizer (Protein Technologies, 
Tucson, AZ) utilizing a standard Fmoc peptide chemistry protocol on a 100 µmol scale.  Five-
fold excess of Fmoc-amino acids (Fmoc-Arg(Pbf)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, 
Fmoc-d-Pro-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-Gln(Trt)-OH, Fmoc-Leu-OH, and HCTU, 
in the presence of 10 equivalents of NMM, were used for each of the amino acid coupling steps 
(10 min) with NMP as the solvent.  Once the peptide synthesis was complete, the resin was 
manually washed with DMF (3x30 sec) and drained.  The peptidylsulfonamide resin was 
activated by suspending the resin in DMF (3 mL) then adding DIEA (87 µL, 5 eq.) and 
iodoacetonitrile (170 µL, 23.5 eq.).  The resin suspension was gently shaken in the dark for 24 
hours.  The resin was then drained and washed with DMF (3 x 3 mL) followed by THF (3 x 3 
mL). Just prior to the completion of the resin activation, Boc-Gly-AFC (193 mg, 5 eq.) was 
stirred in the dark in a round bottom flask containing a solution of TFA:DCM (3 mL, 1:1) for 10 
minutes.  The solvent mixture was removed by a rotary evaporator and the residue was dissolved 
in THF (3 mL).  DIEA (348 µL, 20 eq.) was added to the H-Gly-AFC solution and transferred to 
the now activated resin.  The resin slurry was gently shaken in the dark for 24 hours after which 
the resin was filtered and washed with a small amount of THF.  The combined THF solutions 
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were evaporated and the residue was dissolved in a solution of TFA:water (3 mL, 1:1).  The 
solutions containing the peptides were shaken in the dark for 4 hours to fully deprotect the 
peptides. Cold diethyl ether was then added to the peptide solutions to precipitate the crude 
peptides.  The peptides were centrifuged for 10 minutes (4,000 rpm) and the ether layer 
decanted.  Fresh cold diethyl ether was added, and the pelleted peptide was resuspended.  The 
peptide was centrifuged again, and the procedure was repeated 5 times in total.  After the final 
ether wash, the peptide pellet was dissolved in 5 mL acetonitrile:water (1:1) containing 0.1% 
TFA, frozen and lyophilized.  
Peptide 4 [Ac-RWVRVpGO(FAM)WIRQLRGG-NH2] was synthesized on a Tribute 
peptide synthesizer (Protein Technologies, Tucson, AZ) utilizing a standard Fmoc peptide 
chemistry protocol on a 100 µmol scale using rink amide resin (189 mg, 0.53 mmol/g).  Five-
fold excess of Fmoc-amino acids (Fmoc-Arg(Pbf)-OH, Fmoc-Trp(Boc)-OH, Fmoc-Val-OH, 
Fmoc-d-Pro-OH, Fmoc-Gly-OH, Fmoc-Ile-OH, Fmoc-Gln(Trt)-OH, Fmoc-Orn(Aloc)-OH), 
Fmoc-Leu-OH and HCTU, in the presence of 10 equivalents of NMM were used for each of the 
amino acid coupling steps (10 min) with DMF as the solvent.  A solution of acetic anhydride, 
NMM and NMP (1:1:3) was added to the Fmoc-deprotected resin and shaken for 30 minutes to 
acetylate the N-terminus of the peptide.  Once the peptide synthesis was complete, the resin was 
washed with DMF (3x30 sec) then DCM (3x30 sec).  The Aloc group was removed with three-
fold excess of palladium in 4 ml of CHCl3-HOAc-NMM (37:2:1) under nitrogen for 2 hrs.  The 
resin was then washed with DCM (3x30 sec) followed by DMF (3x30 sec).  In the dark, FAM 
was coupled to the delta nitrogen of the ornithine side chain with four-fold excess of FAM, 
HOBt, PyBOP and DIEA in 3mL DMF for 24 hrs and then repeated for 8 hours.  The peptide 
resin was washed with DMF (3x30 sec) and DCM (3x30 sec).   The peptide was cleaved from 
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the resin and side-chain deprotected using TFA/water/TIPS (4 mL, 95:2.5:2.5) for 3 hours and 
collected in a 50 mL centrifuge tube.  The cleavage reaction was repeated for 10 minutes. The 
cleavage solutions for the peptide was combined and concentrated in vacuo.  Cold diethyl ether 
was then added to the peptide solution to precipitate the crude peptide.  The peptide was 
centrifuged for 10 minutes (4,000 rpm) and the ether layer decanted.  Fresh cold diethyl ether 
was added, and the pelleted peptide was resuspended.  The peptide was centrifuged again, and 
the procedure was repeated 5 times in total.  After the final ether wash, the peptide pellet was 
dissolved in 5 mL water containing 0.1% TFA, frozen and lyophilized.   
HPLC analysis was performed on all peptides with a Waters 616 pump, Waters 2707 
Autosampler, and 996 Photodiode Assay Detector which are controlled by Waters Empower 2 
software. The separation was performed on an Agilent Zorbax 300 SB-C18 (5 um, 4.6 x 250 
mm) with an Agilent guard column Zorbax 300 SB-C18 (5 um, 4.6 x 12.5 mm).  Elution was 
done with a linear 5% to 55% gradient of solvent B (0.1% TFA in acetonitrile) into A (0.1% 
TFA in water) over 50 min at a 1 mL/min flow rate with UV detection at 442 nm.  Preparative 
HPLC runs were performed with a Waters prep LC Controller, Waters Sample Injector, and 2489 
UV/Visible Detector which are controlled by Waters Empower 2 software. The separation was 
performed on a Agilent Zorbax 300SB-C18 PrepHT column (7 um, 21.2× 250 mm) with Zorbax 
300SB-C18 PrepHT guard column (7 um 21.2 × 10 mm) using a linear 5% to 55% gradient of 
solvent B (0.1% TFA in acetonitrile) into A (0.1% TFA in water) over 50 min at a 20 mL/min 
flow rate with UV detection at 215 nm.  Fractions of high (>95%) HPLC purity of each peptide 
and with the expected mass were combined and lyophilized. 
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5.2.3 Cell Culture and Lysate Generation 
HeLa and OPM-2 cells were cultured as described in Chapter 2.3.3. Cell lysates were 
generated and quantified using the methods explained in Chapter 2.3.3. 
5.2.4 Analysis of Enzyme-Substrate Kinetics in Cell Lysates 
All peptides used in the study were reconstituted in dimethyl sulfoxide (DMSO) with the 
final concentration identified using a NanoDrop spectrophotometer as described in 
Chapter.2Quantification of peptide concentration was modified in this chapter by first diluting 
the peptide in 5 M Guanidium Hydrochloride (1:5) prior to measurement. The peptide was 
further diluted as needed in assay buffer (50 mM HEPEPS, pH 7.4, 150 mM NaCl, 2 mM DTT, 
and 0.02% Tween-20). Peptides were mixed with cell lysates and assay buffer in 96-well plates 
with a final volume of 100 µL. Cell lysates were diluted to a final concentration of 4 mg/mL as 
determined using the NanoDrop. To interrogate the role of DUBs on peptide hydrolysis, the 
reaction mixtures were supplemented with PR-619 at two concentrations (20 or 50 µM) or a 
vehicle control of DMSO. Peptide only (noise/background) samples were also included in the 
96-well plate to confirm that the rates observed were due to cell lysates. Different concentrations 
of the peptides were added to wells in the 96-well plate and incubated at 30°C. The fluorescent 
signals emitted as a result of DUB-mediated cleavage of AFC were quantified using a plate 
reader (Perkin Elmer Wallac 1420 Victor2 multilabel HTS counter) using λex= 380 nm and λem= 
500 nm light every 30 min for 6 h. A calibration curve was generated for known concentrations 
of AFC to correlate the fluorescent signal (AU) to concentration (µM). The approximate 
concentration of free fluorophore was used to calculate reaction rates (µM/min) for each 
substrate concentration using linear regression analysis as detailed in Chapter 5.2.7. Control 
experiments were performed using Peptide 3. 
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5.2.5 Analysis of Enzyme-Substrate Kinetics in Intact Cells 
HeLa cells cultured in T-75 flasks were washed with PBS and trypsinized to facilitate 
detachment. Cells were diluted in ECB to a concentration of 10
4
 cells/ml in a total volume of 100 
µL in a 96-well plate. Peptide was reconstituted in sodium phosphate buffer (same recipe as 
chapter 2.3.4) and diluted in ECB (same recipe as chapter 2.3.4). Intact cells were incubated with 
peptide solutions at varying concentrations in the 96-well plate at 30°C in the dark. Fluorescent 
signals were quantified using the same protocol described above. Data was collected every 60 
min for 6 h. Experiments were repeated using Peptide 3. Peptide only controls in absence of 
intact cells were performed to confirm that the observed rates were due to DUB activity in the 
cells. Additional control experiments were performed by incubating the AFC fluorophore with 
intact cells. 
5.2.6 Quantification and Visualization of Peptide Uptake in Intact Cells 
Peptide 4 was synthesized to observe the internalization process of the DUB reporter. 
Unlike Peptide 1, the FAM-conjugated peptide constantly emits a fluorescent signal allowing for 
facile tracking. HeLa cells were seeded on Falcon culture slides (Corning) 24 h prior to 
experimentation. On the day of experiment, the culture media was removed, and the cells washed 
with ECB. Cells were incubated with a 30 µM peptide solution for varying durations of time (10, 
30, 60, and 90 min) to analyze the time dependence of peptide internalization. To assess cell 
viability and intracellular localization, the 90-minute sample was co-incubated with 4 µM 
Ethidium homodimer (Life Technologies) and 8 µM Hoechst (Thermo Fisher Scientific) stains 
for an additional 30 minutes and immediately imaged. Concentration-dependent experiments 
were performed with cells incubated with a peptide solution for 90 min. Samples were imaged 
using brightfield, FITC, DAPI and Rhodamine channels. The details of peptide reconstitution 
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and quantification and the fluorescent microscopy protocol are detailed in Chapter 2 (Section 
2.3.7). Fluorescent images (gray scale) were processed and quantified in gray values using the 
particle analysis and thresholding tabs in Image J. 
5.2.7 Direct Visualization of DUB Activity in Single Intact Cells  
HeLa cells were seeded on culture slides as previously described in Chapter5.2.6. On the 
day of experiment, the culture media was removed, and the cells washed with ECB. 
Concentration dependent studies were performed by incubating varying concentrations (80, 100, 
120, and 160 µM) of Peptide 1 with the cells for 90 minutes at 37. Samples were immediately 
imaged using brightfield and DAPI channels. To visualize the increase in DUB-mediated 
cleavage of the peptide over time, the 160 µM sample was further incubated with ECB supplied 
with 5% Fetal Bovine Serum (FBS) and imaged after 60, 90, and 120 minutes using brightfield 
and DAPI filters.  
5.2.8 Statistical Analysis and Numerical Modeling 
All data visualization, statistical analyses, and numerical simulations in this chapter were 
performed using Origin Pro software unless otherwise specified. The analyses of enzyme-
substrate reactions in cell lysates started with scatter plotting the fluorometry signals (µM) 
measured for each substrate concentration against time (min). Data points for each substrate 
concentration demonstrated a linear increase with time as assessed by linear regression and 
ANOVA statistics. The slopes of each line corresponded to the reaction rate for that substrate 
concentration. Rates were then plotted against substrate concentrations in Figures 5.3 and 5.4. 
Non-linear regression analysis was performed to fit the classic Michaelis-Menten enzymology 
rate equation to the data using the Levenberg Marquardt iteration algorithm to calculate the rate 
constants Km and Vmax.  
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V= enzyme-substrate reaction rate 
[S]= substrate concentration 
vmax = Saturation rate 
Km= Substrate concentration corresponding to vmax/2 
Standard Chi-squared tests and ANOVA statistics were used to assess the goodness of the fit in 
each case. A similar approach was taken to analyze and simulate the enzyme-substrate reaction 
rates in intact cells. Reaction rates for each initial peptide concentration were calculated by 
plotting the concentration against time, performing linear regression analysis, and calculating the 
slopes of each line as detailed above. The rates were plotted against substrate concentrations in 
Figure 5.9 and non-linear curve fitting was performed to simulate the rate data. Due to the added 
complexity of the biophysics of the system encompassing the peptide internalization step, the 
simplistic Michalis-Menten equation failed to fit the data. To account for this, other numerical 
models were explored by trial and error, and the Hill enzymology model was found a good fit for 








V= enzyme-substrate reaction rate 
[S]= substrate concentration 
vmax = Saturation rate 
Km= Substrate concentration corresponding to vmax/2 




5.3 Results and Discussion 
5.3.1 Kinetic characterization of the peptide reporter in cell lysates 
Two peptide-based reporters were synthesized consisting of the RWRWR protectide outlined in 
Chapter 2 and a DUB-specific substrate derived from the C-terminus of ubiquitin (Peptide 1 and 
Peptide 2).  The novel peptides were compared to a commercially available peptide (Peptide 3) 
which was used as a positive control to compare and assess the calculated kinetic rate constants. 
An alternative version of the Peptide 1 peptide was synthesized removing the AFC and 
conjugating a FAM tag to position 8 on the peptide to characterize uptake. All peptide names and 
sequences are included in Figure 5.1A. The structure of Peptide 1 is included 
 
 
Figure 5.1. Sequence and structure of peptides(A) Library of the tested peptides including two 
novel DUB reporters (Peptide 1 and Peptide 2) demonstrating a β-hairpin structure, a 
commercially available DUB substrate (Peptide 3) used as positive control, and the RW-
LRGG peptide conjugated to a FAM tag (Peptide 4) used to characterize the uptake kinetics of 
the DUB reporter (Peptide 1). (B) the structure Peptide 1 demonstrating the β-hairpin bend 
conferring protease resilience to the peptide 
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in Figure 5.1B. All results are representative of multiple experiments with each data point 
measured in triplicate every time. 
 
Standard enzymology studies were performed to characterize the performance of the novel 
peptide-based reporters in cell lysates and demonstrate their application as DUB reporters. The 
observed increase in fluorescent signal due to DUB-mediated hydrolysis for Peptides 1-3 
demonstrated a linear increase over time (data now shown). ANOVA statistics performed to 
assess the convergence of the numerical iterations confirmed that slopes (concentration vs. time) 
of all lines were significantly different from zero by reaching p-values <0.00001. In all cases, R-
squared values of above 95 were reached for the trendlines. Based on this, the slopes of the 
simulated trendlines at six different concentrations representing reaction rates were generated for 
Peptides 1-3 (Figure 5.2). A significant decrease in reaction rates was observed for Peptides 1 
and 3 when the lysates were pre-treated with 20 µM PR-619 (Figure 5.2A, C). The effect was 
further pronounced in samples pre-treated with 50 µM PR-619. This demonstrated that Peptide 1 
was is sensitive DUB-mediated cleavage and that the observed increase in fluorescent signal was 
Figure 5.2. DUB-substrate reaction rates in HeLa lysates Peptides (A) Peptide 1 (B) Peptide 
2, and (C) Peptide 3 (positive control) at varying concentrations were incubated with 4mg/ml 
HeLa lysates in presence and absence of 20 µM and 50 µM DUB inhibitor PR-619. 
Fluorescent outputs were measured every 30 minutes for 6 hours. AFC and AMC calibration 
curves were used to convert signals to concentration units (µM), and linear regression 
analysis on the time dependent signals was used to calculate the reaction rates (slope of the 
line) for each peptide concentration.  
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due to DUB activity and not protease-mediated degradation of the peptide. This was expected 
due to the stability of the RWRWR peptide and its resistance to protease and peptidase activity
61
. 
Conversely, the observed reaction rates for Peptide 2 was highly similar between PR-619 treated 
lysates and DMSO-treated lysates did. Peptide 2 demonstrated a lower overall specificity to 
DUBs (Figure 5.2B) which was coupled with slower reaction rates when compared to Peptides 1 
and 3 (Table 5.1). Non-linear regression analysis using the Levenberg-Marquardt iteration 
algorithm was then performed to calculate reaction rate constants (Km and vmax) for Peptides 1-3 
in the absence of PR-619. The calculated values for vmax (enzyme saturation rate) and Km 
(substrate concentration corresponding to a rate of Vmax/2), the corresponding standard errors 
calculated for each parameter, and the p-values obtained for the convergence of the simulation 
curve (goodness of the fit) were all assessed by ANOVA statistics (Table 5.1). This analysis 
found that the classic Michaelis-Menten enzymology model (Equation 5.1) was a good fit to 
model the data obtained for Peptides 1 and 3. Peptide 1 demonstrated a higher vmax value, and a 
higher Km value compared to Peptide 3. This suggested that higher concentrations of Peptide 1 
were required to reach the same reaction rates using Peptide 3; however, a higher saturation rate 
(vmax) could eventually be reached with Peptide 1. 
 
Table 5.1. Kinetic parameters in HeLa lysates. Non-linear numerical curve fitting was 
performed to fit the rate data obtained for the three peptides to the classic Michaelis-Menten 
enzymology model equation. The data for Peptide 1 and Peptide 3 in HeLa lysates were found 
to be good fits for this equation. Michaelis-Menten rate constants, the standard error 
calculated for each parameter, and the p-value for the goodness of the fit as assessed by 
ANOVA statistics are presented in this table.  
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 To investigate this observation, the vmax/Km (herein referred to as V/K) values were calculated to 
be 2.09x10
-4
 for Peptide 1 and 2.44x10
-3
 for Peptide 3. The 10-fold increase in the V/K values 
obtained for Peptide 3 translated to a better performance to quantify DUB activity in HeLa cell 
lysates. Iteration with the Michaelis-Menten model equation did not converge for Peptide 2 
which suggests that this equation was not a good fit for this peptide. As such, it was suspected 
that the calculated Km and Vmax values for Peptide 2 were not reliable. Due to its reduced DUB 
specificity and slower reaction rate data (Figure 5.2B) in HeLa lysates, further mathematization 
of its rate data considering more complex enzymology models was not attempted.  
To compare the performance of Peptides 1 and 3, a second set of experiments were performed 
using lysates obtained from the myeloma-derived cell line OPM-2. OPM-2 cells have been 
demonstrated to show increased DUB activity, with some cells showing resistance to proteasome 
inhibitors
87
. Similar to what was observed in HeLa lysates, Peptides 1-3 all demonstrated a linear 
increase in concentration versus time with the same level of confidence which allowed for the 
calculation of the reaction rates based on the slope of the line. A similar mathematical analysis 
was performed to model the enzyme-substrate kinetics for Peptides 1-3 in OPM2 lysates as was 
performed for HeLa lysates (Figure 5.3). The results of the non-linear regression analyses for 
Peptides 1-3 are presented in Table 5.2. Peptides 1-3 were all observed to have a difference in 
the concentration-dependent reaction rates between PR-619-treated lysates and DMSO-treated 
lysates.  
Additionally, all three peptides exhibited enhanced reaction kinetics in OPM-2 lysates compared 
to HeLa lysates. This result was expected due to the increased level of DUB activity in 
myeloma-derived cell lines.
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 The Michaelis-Menten kinetic model was found to provide a good 
fit for the reaction rate data for Peptides 1-3 as assessed by ANOVA statistics (p-values 
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presented Table 5.2). The V/K values were calculated to be 6.02x10
-4 
for Peptide 1, 3.9x10
-4 
for 
Peptide 2, and 1.37x10
-3
 for Peptide 3.  
 
 
Again, Peptide 3 was found to exhibit optimal reaction kinetics in OPM-2 lysates; however, only 
a 2-fold increase in the V/K value was observed compared to Peptide 1. This is in contrast to an 
observed 10-fold increase in V/K of Peptide 3 over Peptide 1 in HeLa lysates.  
 
 
Figure 5.3. DUB-substrate reaction rates in OPM-2 lysates Peptides (A) Peptide 1 (B) 
Peptide 2, and (C) Peptide 3 (positive control) at varying concentrations were incubated with 
4mg/ml OPM-2 lysates in presence and absence of 20 µM and 50 µM DUB inhibitor PR-619. 
Fluorescent outputs were measured every 30 minutes for 6 hours. AFC and AMC calibration 
curves were used to convert signals to concentration units (µM), and linear regression 
analysis on the time dependent signals was used to calculate the reaction rates (slope of the 
line) for each peptide concentration.  
 
 
Table 5.2. Kinetic parameters in OPM-2 lysates. Non-linear numerical curve fitting was 
performed to fit the rate data obtained for the three peptides to the classic Michaelis-Menten 
enzymology model equation. Data obtained for all peptides in OPM-2 lysates were found to 
be good fits for this equation. Michaelis-Menten rate constants, the standard error calculated 
for each parameter, and the p-value for the goodness of the fit as assessed by ANOVA 
statistics are presented in this table.  
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This suggests that the difference in reaction rates between peptides is cell type dependent.  As 
was the case in HeLa lysates, Peptide 2 was found to exhibit lower rate constants when 
compared to Peptide 1. 
This confirmed the finding that increasing the length of the substrate from 4 amino acids to 8 
amino acids did not improve reporter performance in cell lysates. Based on this, it was concluded 
that Peptide 2 was a less efficient reporter of DUB activity. Interestingly, this finding 
contradicted the initial hypothesis that the longer substrate would provide enhanced specificity 
towards the DUBs due the extension of the binding substrate. Similar results were previously 
reporter by Melvin et. al. where they observed lower efficiencies with longer substrates
4
. As a 
result of this observation, subsequent characterization of reporter performance was restricted to 
Peptides 1 and 3 in the following sections.  
5.3.2 Quantification of peptide uptake dynamics in intact cells 
 
To effectively model peptide performance in intact cells, it was first necessary to quantify 
peptide uptake kinetics. To accomplish this, Peptide 4 was synthesized which was conjugated to 
a 5,6-carboxyfluorescien tag to visualize peptide uptake and intracellular distribution using 
fluorometry and fluorescent microscopy in HeLa cells as previously described in Chapters 2.
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However, studies have found that the attachment of cargoes to CPPs can alter their uptake 
kinetics
31
, time- and concentration- dependent single cell microscopy experiments were 
performed with HeLa cells. Time-dependent internalization was observed for Peptide 4 with very 
few cells internalizing the peptide after 10 min (Figure 5.4A) whereas the majority of cells has 
taken up the peptide after 90 min (Figure 5.4D).  Intermediate uptake was observed after 
incubation times of 30 min (Figure 5.4B) and 60 min (figure 5.4C) with a greater degree of 
peptide uptake correlating to a longer incubation time. The high background fluorescence 
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observed in Figures 5.4A and 5.4B corresponds to the presence of free peptide on the coverslip. 
Additionally, a few cells exhibited minimal to no peptide uptake which makes them darker than 
the background. This background fluorescence decreases in Figures 5.4C and 5.4D due to the 
higher degree of peptide uptake as a result of a higher incubation concentration.  
 
 
Figure 5.4. Time dependent live cell fluorescent microscopy demonstrating uptake kinetics of 
the DUB reporter 30 µM Peptide 4 peptide was incubated with HeLa cells previously seeded 
on glass coverslips for (A) 10 (B) 30 (C) 60 and (D) 90 minutes at 37 °C in the dark and 
illustrated immediately using brightfield and FITC filters. Scale bar is 40 µm. 
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Peptide uptake was again found to be strongly concentration-dependent with a significant 
increase in intracellular fluorescence observed at higher peptide concentration. Cellular viability 
was assessed in HeLa cells incubated with 30 µM peptide solution for 60 minutes by counter-
staining cells with Ethidium Homodimer-1 (Eth-D1) (Figure 5.5). Intracellular peptide 
distribution was also visualized along with Hoechst staining to denote the nucleus (Figure 5.5) 
which demonstrated a homogeneous distribution that covered the entire cell area. The absence of 
any signal in the Rhodamine channel confirmed that peptide uptake did not decrease cellular 
viability and that a 90 min incubation time with 30 µM peptide solution was sufficient to deliver 
the peptide to cell. Similar uptake dynamics were observed in OPM-2 cells (data not shown). 
 
  Once the incubation time was identified, the next step was to identify an optimal peptide 
solution concentration. This was accomplished by incubated HeLa cells with four different 
concentrations (80, 100, 120, and 160 µM) of Peptide 4 for 90 min at 37°C (Figure 5.6) Peptide 
uptake was monitored using fluorescent microscopy to illustrate an overall positive trend 
between intracellular fluorescence and peptide concentration. HeLa cells incubated with lower 
concentrations of Peptide 4 (Figure 5.6A) were found to exhibit an accumulation of peptide near 
Figure 5.5. Cell viability and intracellular distribution of the RW-LRGG-FAM peptide in intact 
HeLa cells. Cells incubated with 30 µM RW-LRGG-FAM were washed and co-incubated with 
4µM Ethidium Homodimer and 8 µM Hoechst stains. Channels were immediately imaged using 
Brightfield, FITC, DAPI, and Rhodamine filters. The absence of any signal in the Rhodamine 
channel confirms cell viability and it is observed that peptide is homogeneously distributed in the 
cytoplasm of HeLa cells covering the entire cell area. 
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the nucleus while increased concentrations (Figure 5.6B-C) resulted in a more homogeneous 
distribution across the entire cytoplasm until the cells were saturated with a 160 µM peptide 
solution (Figure 5.6D).  
 
 
Figure 5.6. Visualization of the concentration dependent increase in RW-LRGG-FAM 
peptide uptake. Varying concentrations (A) 80 (B)100 (C)120, and (D) 160 µM of the RW-
LRGG-FAM peptide were incubated with intact HeLa cells for 90 minutes at 37 °C in the 
dark and immediately visualized using Brightfield and FITC filters 
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The concentration-dependent effect of intracellular peptide distribution can be attributed 
to peptide internalization pathways. Prior reports found that initial peptide concentration can 
alter the internalization mechanism and intracellular peptide distribution
52
. Cells treated with 160 
µM Peptide 4 were found to have a homogenous distribution across the entire cell. This contrasts 
with the lower concentrations where there appeared to be a greater accumulation of peptide near 
the nucleus. Interestingly, a decreased level of cell to cell variability was observed in cells 
incubated with the upper range of concentrations. To investigate this, the fluorescent signals 
from single HeLa cells incubated with four different concentrations of Peptide 4 were processed 
and quantified (Figure 5.7). This analysis found that cells incubated with peptide concentration 
below 120 µM demonstrated a high degree of cell to cell variability representative of population 
heterogeneity (Figure 5.7A). Conversely, cells incubated with 160 µM peptide exhibited a much 
more homogeneous distribution. A positive correlation was observed between the mean values of 
the fluorescent uptake and peptide concentration which was saturated with the 160 µM peptide 
concentration (Figure 5.7A). To better characterize the population distribution of peptide uptake 
in single cells, the data for the 120 µM sample (Figure 5.7B) and 160 µM sample (Figure 5.7C) 
were analyzed in terms of population distribution. It was observed that cells incubated with 120 
µM Peptide 4 solution demonstrated a bimodal distribution which found to be a great fit for the 
bigaussian equation (chi-squared=10
-9
, r-squared=0.67, p-value<0.0001). A more homogenous 
intracellular distribution (Figure 5.6 D) was visualized by fluorescent microscopy and a 
decreased level of population heterogeneity was observed for cells incubated with 160 µM 
Peptide 4 solution (Figure 5.6 C).   
These findings were used to determine the optimal peptide concentrations to be used for 
measuring DUB activity. Since a saturation level of peptide uptake was observed with the 160 
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µM peptide solution incubated for 90 minutes, it was decided that increasing peptide 
concentration beyond that range would be unnecessary.  
 
Figure 5.7. Concentration dependent uptake of Peptide 4  in intact HeLa cells Quantified 
values obtained from processing fluorescent images (A) bar graphs and single cell data points 
of peptide uptake for varying peptide concentrations (n80=111, n100=154, n120=124, n160=58 ) 
(B) Population distribution of cells incubated with 120 µM peptide for 90 minutes 
demonstrating a bigaussian distribution identifying two peaks (chi-squared tolerance=10
-9
, r-
squared=0.67, p<0.0001) (C) Population distribution of cells incubated with 160 µM peptide 
for 90 minutes demonstrating a reduced level of population heterogeneity 
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 Additionally, the homogenous cytosolic and nuclear distribution of peptide at this 
concentration (Figure 5.6) would allow for an unbiased measurement of DUB activity 
throughout the cross-sectional area of a single cell eliminating the concern that the lack of signal 
in a sub-cellular region would be due to the absence of peptide versus the decreased level of 
DUB activity in that area. Similarly, the peptide was ultimately intended to measure DUB 
activity in single intact cells and characterize the population heterogeneity in terms of DUB 
activity. Ideally, the observed population distributions would be confidently attributable only to 
DUB activity and not cell-to-cell variability of peptide uptake. Therefore, based on the more 
homogenous response in terms of peptide uptake observed for the 160 µM sample (Figure 5.7 C) 
it was decided that this was the optimal peptide concentration for performing single cell studies 
using fluorescent microscopy (section 5.3.4). 
5.3.3 Kinetic characterization of the peptide-based DUB reporter in intact cells 
To demonstrate the application of Peptide 1 for measuring DUB activity in intact cells, 
HeLa cells were incubated with increasing concentrations of Peptide 1 and Peptide 3 and 
quantified using fluorometry. Peptide 3 is a non-permeable reporter, so while it was used as a 
positive control above, it is now used as a negative control. Similar to results obtained from the 
lysate studies (Chapter 5.3.1), the bulk fluorescent signals observed for HeLa cells incubated 
with each peptide concentration demonstrated a linear, time-dependent increase as assessed by 
linear regression analysis (data not shown). ANOVA statistics were performed to confirm that 
the slopes of the lines were significantly different from zero. In all cases, r-squared values >95 
and p values <0.000001 were reached for the fitted lines confirming the presence of the linear 
trends. As a result, the slopes of the lines were calculated to obtain the reaction rates presented in 
Figure 5.8. As illustrated in Figure 5.8A, Peptide 1 yielded significantly higher reaction rates 
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compared Peptide 3. The fluorescent profile demonstrated a direct correlation with substrate 
concentration indicating that higher reaction rates were reached by incubating cells with a higher 
concentration of Peptide 1. This was not the case for Peptide 3 or the Peptide 1 only (no cells) 
samples. This confirmed that Peptide 1 is capable of measuring DUB activity in intact cells while 
its commercial counterpart (Peptide 3) fails to facilitate such measurements. The absence of the 
concentration-dependent increase in rates quantified for the peptide only samples confirms that 
the observed rates were due to the presence of the cells, and the peptide by itself did not produce 
an increase in fluorescent signals (data not shown). 
 
Figure 5.8 Enzyme-substrate kinetics of DUB reporters in intact HeLa cells. HeLa cells (10
4 
cells/ml) were incubated with varying concentrations of the RW-LRGG-AFC and the Z-
LRGG-AMC peptides in a total well volume of 100 µL in a 96-well plate in addition to RW-
LRGG-AFC peptide only controls. AFC and AFC fluorophores were detected using 
appropriate protocols every 30 minutes for a duration of 6 hours. (A) Enzyme-substrate 
reaction rates for (B) Hill model fitted to rate date obtained for the RW-LRGG-AFC peptide 
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The reaction rate data for HeLa cells incubated with Peptide 1 were further analyzed by 
non-linear regression. Again, Michaelis-Menten kinetics failed to fit this data and iterations 
performed using the Levenberg-Marquardt algorithm did not converge. Interestingly, like the 
concentration-dependent uptake studies described in Figure 5.7B, the Hill enzymology model of 
cooperative binding was found to be a good fit for the data (Table 5.3). Iterations converged 
obtaining a chi-squared value of 6x10
-9
, and an r-squared value of 0.96. The goodness of the fit 
was assessed by ANOVA statistics contrasting the Hill curve to the function y=constant (null 
hypothesis) which resulted in p<0.005, confirming the goodness of the fit. The kinetics rate 
constants calculated using the Hill equation for Peptide 1 are presented in Table 5.3 along with 
the standard error and p-value for each parameter. 
 
 
5.3.4 Direct quantification of DUB activity in intact cells using fluorescent microscopy 
While the fluorometry experiments provided a justification for the ability of Peptide 1 to 
measure DUB activity in intact cells, they were not capable of providing insight into the single 
cell response. To examine single cell DUB activity, both concentration-dependent and time-
dependent studies were performed using Peptide 1 in HeLa cells. HeLa cells were incubated with 
Peptide 1 for 90 min, washed, and then imaged to measure DUB activity (Figure 5.10). The role 
Table 5.3 Hill enzyme-substrate rate constants in intact HeLa cells. Non-linear numerical 
curve-fitting was performed to fit the rate data obtained for the RW-LRGG-AFC peptide in 
intact HeLa cells to the Hill enzymology model equation. Hill rate constants, the standard 
errors calculated for each parameter, and the p-value for the goodness of the fit as assessed by 
ANOVA statistics are presented in this table.  
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of peptide concentration was first studied by incubating the cells at four different peptide 
concentrations and then immediately imaging them (Figure 5.9).
 
 
Cells incubated with 120 µM peptide solution and higher were found to immediately 
yield a detectable signal while cells incubated with lower peptide concentrations exhibited a 
diminished fluorescent signal. This confirmed the findings from above that a higher 
concentration of peptide was needed to visualize DUB activity in cells. Next, time-dependent 
DUB activity was assessed in HeLa cells incubated with 160 µM Peptide 1. An increase in 
intracellular fluorescence was immediately observed at the start of the time course and continued 
to increase until 100 min (Figure 5.10).  
Interestingly, discrete regions of DUB activity were observed near the nucleus 
immediately after peptide removal (Figure 5.10, t=0 min). Continual imaging of the sample after 
60 min illustrated a more uniform level of DUB activity. Moreover, higher fluorescent intensities 
were observed in cells after a 60 min period with brighter fluorescence around the nuclear 
envelope (Figure 5.10, t=60 min). After 60 minutes the intracellular fluorescence started to 
Figure 5.9. Concentration-dependent quantification of DUB activity in single intact cells 
HeLa cells seeded on glass coverslips were incubated with varying concentrations of the DUB 
reporter peptide (RW-LRGG-AFC) for 90 minutes at 37 °C. Peptides were removed, cells 
were washed with ECB and imaged immediately using brightfield and DAPI filters. 
Overlayed channels are illustrated. Scale bar is 40 µm.  
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diminish which was suspected to be a result of the internalized peptide reporter being consumed 
in the intact cells. 
 
 
A similar experiment was performed incubating Peptide 1 in the myeloma-derived OPM-
2 cells (Figure 5.11) with similar results.  
 
 
Figure 5.10. Time-dependent observation of DUB activity in single intact cells HeLa cells 
seeded on glass coverslips were incubated with varying concentrations of the DUB reporter 
peptide (Peptide 1) for 90 minutes at 37 °C. Peptides were removed, cells were washed with 
ECB and further incubated with ECB. Time points were visualized using brightfield and 
DAPI filters. The DAPI channel is illustrated for 4 time points (0, 60, 100, and 120 
minutes). Scale bar is 40 µm.  
 
Figure 5.11. Direct visualization of DUB activity in OPM-2 cells OPM-2 cells were 
incubated with 50 µM of (A) Peptide 1 and (B) Peptide 3 for 120 minutes in microcentrifuge 
tubes at 37 °C. Peptides were removed and cells were washed with ECB and immediately 
visualized using a DAPI filter. Scale bars are 20 µm. 
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OPM-2 cells incubated with Peptide 1 showed an increase in intracellular fluorescence 
due to DUB-mediated hydrolysis of the reporter (Figure 5.11A). Expectedly, OPM-2 cells 
incubated with Peptide 2 did not produce a detectable signal (Figure 5.11B). These observations 
demonstrate the capability of Peptide 1 to directly quantify DUB activity in single intact cells.   
5.4 Conclusions 
In this work, a novel reporter of DUB activity (Peptide 1) was introduced. Peptide 1 was 
confirmed to be sensitive and specific to DUBs as assessed by fluorescence-based enzymology 
studies in HeLa and OPM-2 lysates. Non-linear regression analysis and ANOVA statistics 
characterized the enzyme-substrate reactions and demonstrated that the reporter kinetic rates 
were comparable to Peptide 3, a commercially available, positive control peptide.  Peptide 1 
successfully distinguished between samples treated with varying concentrations of a small 
molecule inhibitor of DUB activity (PR-619) as efficiently as its commercial counterpart 
(Peptide 2) to confirm its specificity to DUBs. Furthermore, experiments performed with a 
Peptide 4 (FAM-tagged version of Peptide 1) demonstrated the efficient uptake of the reporter in 
intact cells. Single cell data obtained from fluorescent microscopy were quantified to 
characterize the concentration dependence of peptide uptake and the population distributions of 
select experiments. These data were used to optimize the experimental conditions to measure 
DUB activity in single cells by identifying that a 90-minute incubation period with 160 µM 
Peptide 1 resulted in a homogeneous intracellular peptide distribution and decreased population 
heterogeneity, both of which are considered favorable for performing single cell measurements 
of DUB activity. Finally, Peptide 1 was used to measure the blended bulk quantity of DUB 
activity in intact HeLa cells and identified a time-dependent increase in DUB activity in those 
cells. Reaction rates calculated in intact cells were also found a good fit for the Hill equation. 
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Live cell fluorescent microscopy experiments visualized DUB activity in single intact HeLa and 
OPM-2 cells and identified intracellular regions with increased DUB activity within the cells. 
These results confirmed that, unlike the commercially available DUB reporters that are limited to 
enzyme only or lysate-based studies, the novel reporter introduced here is capable of detecting 
DUB activity in intact cells. This new reporting scheme has vast potential to be incorporated into 
high-throughput single cell screening methods like flow cytometry or droplet microfluidics. Such 
single cell characterizations can provide invaluable information about cell population 
distributions and the underlying subpopulations present in biochemical samples in terms of DUB 
activity, as well as the intracellular levels of DUB activity. Current work is underway to perform 
dynamic measurements on a large number of single intact cells using high-throughput single cell 











Chapter 6: Conclusions and Future Work  
6.1 Conclusions 
The association of deubiquitinating enzymes (DUBs) with several human pathologies, 
including Multiple Myeloma, Alzheimer’s and Parkinson’s diseases, and cardiac diseases like 
Arteriosclerosis thrombosis has made them an attractive pharmacological target. The current 
methods of measuring the activity of DUBs in biochemical samples are limited to cell-free test 
tubes and conventional bulk measurements due to the unavailability of biochemical assays, while 
the heterogeneity associated with such samples, especially in cancer patients makes such bulk 
measurements misleading. In this thesis, an interdisciplinary approach was taken to develop a set 
of bioanalytical toolkits to facilitate direct quantification of deubiquitinating (DUB) enzyme 
activity in single intact cells by means of a cell penetrating peptide-based, fluorescent reporter, a 
droplet microfluidic platform, and numerical single cell analysis and simulation techniques.  
To put the puzzle together, the library of cell penetrating peptides developed in chapter 2 
were used to design a unique CPP-based reporter of DUB activity in chapter 5. An alternative 
strategy for developing protease-resistant CPPs was explored in chapter 3 which led to 
interesting findings about an intracellular mechanism exporting peptides from the cells after 
internalization. While the peptides synthesized in chapter 3 have not yet found an application for 
DUB reporting, these findings provided new information about the use of D-chirality amino 
acids in CPPs. Moreover, this new type of stable, CPP could have potential in reporters for 
DUBs and the proteasome. A microfluidic droplet trapping array was developed in Chapter 4 and 
used to perform high-throughput, single cell analysis of CPP uptake and provide important 
information on the behavior of a population of cancer cells with respect to peptide uptake. The 
work performed in this thesis has provided the foundation for a new bioanalytical platform to 
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directly measure DUB activity in intact single cells in a high throughput manner and other follow 
up studies as detailed in the following sections.  
6.2 Future Work 
6.2.1 High-throughput screening of DUB activity in single intact myeloma cells 
An immediate follow up study is underway using the microfluidic device from Chapter 4 
and the DUB reporter from Chapter 5 to quantify DUB activity across a population of cells 
Experiments will be performed to measure DUB activity in single intact OPM-2 and MM.1S 
cells, two multiple myeloma-derived suspension cell lines. These findings will provide essential 
baseline information on DUB activity and will lead to follow-up studies testing different DUB 
inhibitors in addition to triplet therapeutics targeting both DUB and proteasome activity. 
6.2.2 Development of a β-hairpin-based PROTAC to induce the targeted degradation of 
PTP1B enzyme 
 
Insulin resistance is a major contributor to the connection between obesity and type 2 
diabetes mellitus. Protein tyrosine phosphatases (PTPs) are a family of enzymes responsible for 
dephosphorylating tyrosine residues on the insulin receptor and several downstream effectors. 
One member of this family protein tyrosine phosphate 1B (PTP1B) has become an attractive 
pharmacological target due to its role in developing insulin resistance. In this follow up study, 
the β-hairpin CPP OWRWR from Chapter 2 will be used to develop a new class of PTP1B 
inhibitors that knockdown enzyme activity by peptide directed ubiquitin-proteasome 
degradation. It is hypothesized that the enhanced protease resistance and rapid ubiquitination 
kinetics of the β-hairpin peptides as demonstrated in Chapter 2 will offer superior performance 
(e.g., reduced IC50 values, enhanced uptake, and extended lifetime) in the knockdown of 
PTP1B. 
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6.2.3 Utilize the cell permeable DUB reporter to identify a new class of DUB inhibitors 
Recently, our group has initiated a collaboration with researchers at Pennington 
Biomedical Research Center. Our collaborators have identified a novel plant extract termed 5011 
that has potential in treatment of diabetes. It is hypothesized that this extract also affects the level 
of DUB activity in the treated cells. In this work, the DUB reporter peptides from Chapter 5 are 
being used to measure DUB activity in C1C12 cell lysates and intact cells in the presence and 
absence of these new experimental compounds to characterize their effect on DUB signaling 
pathways.    
6.2.4 Direct quantification of proteasome activity in single intact cells  
In this work, the β-hairpin CPP OWRWR from Chapter 2 will be incorporated into a 
novel reporter of proteasome activity that is cell-permeable and long-lied in the cells. Similar to 
the DUB reporter from Chapter 5, this reporter will be capable of measuring proteasome activity 
in single intact cells and will also be compatible with HTS methods such as the droplet 
microfluidic platform presented in Chapter 4. The reporter will take advantage of a unique 
properties of the β-hairpin peptides and couple them with unstructured regions to produce the 
tripartite degron needed for proteasomal recruitment.  
6.2.5 Development of a thiol acrylate-based hydrogel for tumor spheroid generation in a 
microfluidic device 
The extracellular environment plays an important role in regulating cell behavior. The 
structure and chemical composition of this environment can determine the fate of the growing 
cells. Standard two-dimensional (2D) culturing approaches in flasks fail to replicate the three-
dimensional (3D) environment of the extracellular matrix and the chemical gradients formed in 
such a structure. Hydrogels represent a new approach to emulate this dynamic environment lost 
115 
in traditional two-dimensional culturing methods. Synthetic hydrogels are ideal material for 
simulating the 3D structure of the extracellular environment. A common example of such 
hydrogels is poly ethylene glycol diacrylate (PEGDA). However, this hydrogel as well as most 
of the currently available hydrogels require UV exposure for initiation of the gelation process. A 
future direction based on the work presented here will be to utilize the droplet trapping array 
produced in Chapter 4 to create 3D tumor spheroids from single cells. The microfluidic device 
will be coupled with a novel thiol-acrylate-based hydrogel to create a new platform that does not 
require external initiators like UV exposure or Calcium. The long-term culturing of cells in the 
hydrogel will be facilitated by a continuous media flow in the device channels to allow for the 
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